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ABSTRACT 
Molecular Characterization of Oct4-Expressing Yolk Sac Endoderm Stem Cell Lines. 
(May 2008) 
Bisrat Godefay Debeb, D.V.M., Addis Ababa University, Ethiopia;  
M.S., Tuskegee University 
Chair of Advisory Committee: Dr. Bert Binas 
 
 
The extraembryonic endoderm (XEN) defines the yolk sac, a set of membranes that 
provide essential support for mammalian embryos. Recently, the committed XEN- 
precursor was identified in the embryonic Inner Cell Mass (ICM) as a group of cells that 
intermingles with the closely related, anatomically indistinguishable epiblast (EPI)-
precursor that gives rise to the fetus. In vitro, the EPI-precursor is represented by the 
well-known embryonic stem (ES) cell lines, but cell lines representing the XEN-
precursor are not known. Furthermore, since the XEN-precursor cells were discovered 
only very recently, the unexpected fact that they express the key pluripotency marker 
Oct4 has not been explored. Recently, however, our laboratory has isolated rat XEN cell 
lines that express Oct4, leading to the following two questions: (i) Do these new XEN 
cell lines represent XEN-precursor cells? (ii) Is their Oct4 expression regulated similarly 
as previously known from ES cells? These two questions are addressed here by lineage 
marker and reporter gene analyses.  
 iv 
Whole culture analyses showed that rat XEN cell lines expressed markers of all 
XEN stages including XEN-precursor, primitive endoderm (PrE) and/or visceral 
endoderm (VE), and parietal endoderm (PE) but trophoectoderm and EPI-precursor 
markers were missing. In line with this, immunocytochemistry demonstrated 
heterogeneity and directly visualized the XEN-precursor, PrE/VE, and PE 
subpopulations. Low-density plating and time-dependent immunocytochemistry on 
resulting colonies strongly suggested that XEN-precursor cells generate the other XEN 
stages. Moreover, by analyzing single-cell derived clones, it was shown that culture 
heterogeneity results from the self-renewal and differentiation of a single cell. Reporter 
gene analyses using the 5’ regulatory region of the mouse Oct4 gene revealed that a 
DNA fragment containing the previously described distal enhancer drove reporter gene 
expression only in ES cells whereas inclusion of an upstream fragment led to high 
expression in both mouse ES and rat XEN cells. 
In conclusion, our rat XEN cell lines contain XEN-precursor cells that differentiate 
extensively, providing for the first time an in vitro model that mimics the natural process 
of early XEN differentiation. In addition, they regulate Oct4 gene transcription 
differently than ES cells suggesting heterogeneous Oct4 regulation within the 
mammalian ICM.  
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NOMENCLATURE 
 
dpc  days post coitum 
EC   Embryonic carcinoma cells 
EG   Embryonic germ cells 
EPI   Epiblast  
EPI-P  Epiblast-precursor 
ES  Embryonic stem cells 
ICM   Inner cell mass 
LIF  Leukemia inhibitory factor 
PE  Parietal endoderm 
PrE   Primitive endoderm 
PGCs  Primordial germ cells 
PYS  Parietal yolk sac 
RA  Retinoic acid 
TE   Trophectoderm 
TS   Trophoblast stem cells 
VE  Visceral endoderm 
VYS  Visceral yolk sac 
XEN   Extraembryonic endoderm  
XEN-P Extraembryonic endoderm-precursor 
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CHAPTER I 
 
INTRODUCTION AND LITERATURE REVIEW 
 
Lineage specification in the blastocyst 
 
It is important to understand the morphological changes that lead to formation of 
the blastocyst in order to know the cellular origins of the first three lineages. Following 
fertilization of the oocyte, the zygote cleaves several times leading to the formation of 
the morula. During the morula stage, cells compact against each other by forming 
intercellular junctions. The outer layer of the late morula are epithelized and become 
trophoectoderm (TE) while the inner cells generate the pluripotent inner cell mass 
(ICM). During late blastocyst stages the ICM becomes organized into the epiblast (EPI) 
and primitive endoderm (PrE) cells (Fig. 1; Rossant, 2007). Thus, by the late blastocyst 
stage, the mammalian embryo is composed of three distinct cell types: the TE, EPI and 
PrE, which are committed to their different later lineages and are no longer totipotent. 
The TE is exclusively restricted to form the fetal portion of the placenta and the 
trophoblast giant cells. The EPI gives rise to the entire fetus as well as extraembryonic 
mesoderm cells that line the visceral yolk sac and placental villi. The PrE subsequently 
differentiates into visceral endoderm (VE) and parietal endoderm (PE).  
The VE cells cover the epiblast and extraembryonic ectoderm (trophoblast) at the  
____________ 
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egg cylinder stage of development. VE cells in contact with the trophoblast are more 
columnar and cuboidal, while VE cells overlying the epiblast are flatter and more  
epithelial in shape (Bielinska et al., 1999; Rossant, 2007). The VE cells are 
morphologically and functionally similar to gut endoderm. They have microvilli and 
phagocytic and pinocytic vesicles that allow efficient absorption and digestion of 
maternal nutrients. VE cells also synthesize and secrete proteins involved in nutrient 
transport, such as transferrin and apolipoproteins (Bielinska et al., 1999). While PE cells 
are terminally differentiated, VE cells retain the ability to differentiate into PE (Gardner, 
1983; Ninomiya et al., 2005) and can even trans-differentiate into somatic cells (Sobis et 
al., 1993).   
 
 
 
 
 
 
 
 
 
 
Fig. 1. Stages of early embryonic development and the cell lineages present in vivo. 
The three fundamental cell lineages in a mammalian embryo are the TE, EPI and XEN, 
which give rise to the placenta, fetus and yolk sac, respectively, postimplantation. EPI-P, 
EPI-precursor; XEN-P, XEN-precursor. 
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The PE, a single layer of cells that develops in association with TE, synthesizes 
copious amounts of basement membrane proteins (such as laminin, type IV collagen) to 
form Reichert's membrane in conjunction with the trophoblast giant cell layer (Hogan et 
al., 1980). The combination of PE cells, giant cells and the intervening thick basement 
membrane comprises the early functioning, transient parietal yolk sac.   
 
The first lineage choice (TE vs. ICM) 
Early differentiation of the mammalian embryo leads to the development of two 
distinct lineages, the TE and the ICM. These lineages can be distinguished by the 
expression patterns of several lineage-specific transcription factors. 
An important gene that promotes early TE development is the Caudal-like 
transcription factor, Cdx2 which is expressed in the TE of the blastocyst (Beck et al., 
1995; Strumpf et al., 2005). Cdx2 protein is first detectable in the nuclei of select cells at 
the eight-cell stage (Niwa et al., 2005) and becomes restricted to outer cells of the late 
morula (Niwa et al., 2005; Strumpf et al., 2005). Cdx2 mutant embryos form a normal-
appearing blastocyst, although ICM markers such as Oct4 and Nanog fail to be repressed 
in the TE (Strumpf et al., 2005), indicating a defect in restriction of the ICM/TE lineage. 
Cdx2 mutant TE eventually collapses and undergoes apoptosis, leading to blastocyst 
lethality before implantation.  In addition to Cdx2, transcription factor genes like 
Eomesodermin and Mash2 show a reciprocal pattern of expression to Oct4 in the early 
embryo, becoming restricted to the TE by the blastocyst stage (Ciruna and Rossant, 
1999; Russ et al., 2000; Guillemot et al., 1994; Niwa et al., 2005). Targeted mutation of 
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these genes reveals that they are required for trophoblast lineage development. 
Eomesodermin mutants die shortly after implantation because the TE fails to proliferate 
and presumably fails to provide support for the embryonic lineages (Russ et al., 2000). 
Mash2 mutants develop to E10.5 but die because of placental defects caused by loss of 
spongiotrophoblast (Guillemot et al., 1994). 
The POU (Pit-Oct-Unc) domain transcription factor Oct4 is essential for ICM 
development. Oct4 is initially detectable in nuclei of all cells of the early embryo, but its 
expression becomes restricted to the ICM upon blastocyst formation (Palmieri et al., 
1994). Oct4 mutant mice die around the time of implantation, lack ICM derivatives such 
as epiblast and yolk sac, and only TE-like cells can be recovered (Nichols et al., 1998). 
In addition, no ES cells can be derived from Oct4 mutant blastocysts, and conditional 
knock-down of Oct4 in ES cells results in their transformation into trophoblast-like cells 
(Niwa et al., 2000). Thus, Oct4 is required for ICM specification and maintenance, and 
for suppressing trophoblast cell fate, and the antagonism between Oct4 and Cdx2 
reinforces the ICM/TE lineage fates. Another gene, Sox2 (SRY box containing gene), is 
also believed to be important in ICM cell fate specification. Like Oct4, Sox2 is 
expressed in all blastomeres of the cleavage stage embryo and becomes restricted to the 
ICM and epiblast at the blastocyst stage (Wood and Episkopou, 1999). Mutation of Sox2 
results in early postimplantation lethality with failure of epiblast growth (Avilion et al., 
2003). Cultured Sox2−/− ICM cells show characteristics of differentiated trophoblast 
(Avilion et al., 2003), and thus Sox2 seems to share a role with Oct4 in maintaining ICM 
cell fate. 
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The second lineage choice (EPI vs. PrE) 
At E4.5 in the mouse blastocyst, the second lineage decision leads to the 
establishment of two morphologically distinct populations from the ICM: the EPI, which 
is the embryonic lineage, and the PrE, which will give rise to an extraembryonic tissue, 
the yolk sac endoderm. The PrE forms as a monolayer on the surface of the ICM directly 
facing the blastocoele, while the EPI lies between the PrE and the TE. 
The establishment and segregation of the two lineages within the ICM have been 
understood only recently. Traditionally, it has been thought that ICM cells of the early 
blastocyst are a homogenous population of bipotential cells each with the ability to 
become both EPI and PrE. But recent findings indicate that the early ICM consists of a 
heterogeneous population of cells (Fig. 2). Chazaud et al. (Chazaud et al., 2006) found 
that lineage-specific markers for the EPI and the PrE are expressed in non-overlapping 
manner in the ICM of the early blastocyst before morphological segregation of these two 
lineages. In this study, Oct4 was expressed at equivalent levels in all ICM cells, while 
Nanog and Gata6, the EPI and the PrE-specific transcription factors, were expressed in a 
mutually exclusive manner. Thus, ICM cells expressing Oct4 and Nanog are EPI-
precursors while those expressing Oct4 and Gata6 are PrE-precursors (XEN-precursors). 
Moreover, individual labeled ICM cells from the early blastocyst contributed to either 
EPI or PrE lineages but rarely to both (Chazaud et al. 2006). The finding that the early 
ICM is not homogenous was supported by another study that used single-cell microarray 
analysis (Kurimoto et al., 2006) and showed that individual ICM cells of the early 
blastocyst have distinct EPI-like or PrE-like gene expression profiles. These findings and 
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the segregation and dispersed localization of Nanog and Gata6 expressing cells in the 
ICM suggests that allocation of cells to the EPI and PrE lineages is not influenced by 
any position-specific activity within the ICM, unlike previous thoughts that cell fate 
within the ICM is determined based on their position in the ICM cell cluster.  
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. The new understanding of early embryogenesis. During early blastocyst stage 
(E3.5), the ICM is a mosaic of EPI-precursor and XEN-precursor cells that both express 
Oct4 but later (E4.5), it segregates into the EPI and the PrE. 
 
The identification of genes required for PrE formation has given insight into 
mechanisms regulating the initiation and maintenance of EPI/PrE lineage restriction. In 
the late blastocyst, the homeobox transcription factor Nanog is expressed in the EPI 
(Chambers et al., 2003; Mitsui et al., 2003), and the zinc finger transcription factor 
Gata6 is expressed in the PrE (Morrisey et al., 1998; Koutsourakis et al., 1999). The 
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knockout of Nanog in ES cells leads to differentiation to PrE-like cells and expression of 
the PrE marker Gata6 (Mitsui et al., 2003). Similarly, overexpression of Gata6 in ES 
cells leads to differentiation into a PrE-like cells and down-regulation of the EPI marker 
Oct4 (Fujikura et al., 2002; Shimosato et al., 2007). Likewise, Gata6 knockout mice are 
embryonically lethal at E5.5 – 6.5 due to defects in VE differentiation and subsequent 
XEN development (Morrisey et al., 1998; Koutsourakis et al., 1999) and Gata6-null ES 
cells fail to undergo VE differentiation in vivo and in vitro (Morrisey et al., 1998). This 
suggests that Gata6 is required for early XEN, including PrE, as well as for the 
development of both VE and PE. Thus, Nanog and Gata6 appear to be antagonistic, with 
Nanog promoting the EPI formation and blocking the PrE formation while Gata6 
promoting the PrE lineage and blocking EPI formation. This antagonism may reinforce 
EPI and PrE cell fates to promote self-renewal and prevent switching among these 
lineages.  
Similar to Gata6 mutations, the mutations in the transcription factors Hnf4 and 
Gata4 also lead to defective development of the VE (Chen et al., 1994; Watt et al., 
2004). Likewise, loss of Grb2 prevents the formation of PrE and expression of Gata6 
during the late blastocyst stage because Grb2, which encodes an adaptor protein for 
receptor tyrosine kinases, facilitates the sorting of the EPI/PrE lineages in the blastocyst 
(Cheng et al., 1998; Chazaud et al., 2006; Hamazaki et al., 2006).  
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Stem cells from mammalian blastocyst lineages 
Stem cells from the blastocyst have provided a valuable tool for the genetic 
analysis of lineage-promoting factors and have confirmed the central importance of 
transcription factors in maintaining cell fates.  
Permanent cell lines representing the EPI-precursor (called embryonic stem cells) 
and TE (called trophoblast stem cells) have been derived from the mouse blastocyst 
(Evans and Kaufmann, 1981; Martin, 1981; Tanaka et al., 1998). But so far, the third 
stem cell type that represents all the derivatives of the XEN lineage including the ICM-
stage XEN (XEN-precursor) has not been published. In previously described XEN cell 
lines (Fowler et al., 1990; Wewer et al., 1982; Notarianni and Flechon, 2001; Kunath et 
al., 2005; Ouhibi et al., 1995) the key XEN-precursor marker Oct4 was not studied or 
not expressed. Moreover, insofar as studied, these cell lines contribute predominantly to 
the PE and not to the VE in vivo (Kunath et al., 2005). As will be described in detail in 
the forthcoming chapters, our laboratory is the first to isolate the XEN-precursor cell 
lines as evidenced by their molecular signature (including Oct4 expression), 
differentiation potential and repopulation of the PE and VE in chimeras.  
The known mouse blastocyst-derived stem cell types use different signaling 
pathways to maintain stem cell proliferation, require different transcription factor 
expression for specifying the stem cell state, and contribute to their cognate lineage in 
chimeric embryos (Beddington and Robertson, 1989; Tanaka et al., 1998; Kunath et al., 
2005). The properties of the existing stem cell types from the blastocyst will be 
described below.  
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Embryonic stem (ES) cells 
ES cells can be derived from the epiblast lineage of the blastocyst (Evans and 
Kaufmann, 1981; Martin, 1981). They can be obtained in vitro by culture of ICM cells 
of the blastocyst in the presence of the cytokine, leukemia inhibitory factor (LIF) (Smith 
et al. 1988) and are often grown on a layer of mouse embryonic fibroblast ‘feeder’ cells. 
In LIF-supplemented medium, ES cells grow as smooth colonies of rounded cells and 
can grow indefinitely as undifferentiated cells that express markers like Oct4. Upon 
removal of LIF, however, they downregulate Oct4, rapidly lose self-renewal capacity 
and spontaneously differentiate into a variety of cell types of the body (Chambers and 
Smith, 2004). Generation of chimeras by aggregation of ES cells with eight-cell embryos 
or injection of ES cells into blastocysts revealed that ES cells are pluripotent but not 
totipotent. Although they contribute to all tissues of the fetus including the germline, 
they fail to contribute efficiently to the TE or XEN lineages (Beddington and Robertson, 
1989). 
 
Maintaining pluripotency of ES cells 
Pluripotency refers to the ability of a cell to differentiate into various types of 
cells that belongs to all definitive tissues: ectoderm, mesoderm and endoderm. 
Understanding the molecular basis of pluripotency and the conditions required to 
maintain this state in the early embryo is vital for an understanding of the maintenance 
of pluripotent ES cells in culture (Smith, 2001; Niwa, 2007).  
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Maintaining cells in an undifferentiated state requires fine tuning of an intricate 
network of cellular factors that prevents the cell from entering any of the differentiation 
lineages. As will be discussed later in detail, Oct4 is a crucial determinant of 
pluripotency in ES cells as knockout of this gene leads to the formation of TE-like cells 
that are non-pluripotent (Nichols et al., 1998). Besides Oct4, the transcription factors 
Nanog and Sox2 have been identified to contribute to the pluripotency of ES cells 
(Niwa, 2007; Chambers et al., 2003; Mitsui et al., 2003; Avilion et al., 2003). The 
knockout of Nanog leads to conversion of all ICM cells to a PrE phenotype (Mitsui et 
al., 2003) and causes loss of pluripotency in ES cells (Chambers et al., 2003; Mitsui et 
al., 2003). Sox2 shows an expression pattern similar to Oct4 during early embryogenesis 
and its mutation results in early postimplantation lethality with failure of epiblast growth 
(Avilion et al., 2003).  
 
Trophoblast stem (TS) cells 
TS cells can be derived from blastocysts or early postimplantation trophoblast by 
culture in the presence of fibroblast growth factor 4 (Fgf4) plus heparin and primary 
embryo fibroblast-conditioned medium (Tanaka et al., 1998). Under these conditions, TS 
cells grow as epithelial colonies. It has also been shown that members of the 
transforming growth factor b (TGF-b) family Activin (Erlebacher et al., 2004) can 
replace the need for conditioned medium in maintaining the undifferentiated TS state. 
TS cells can be passaged for many generations without differentiation, but upon 
withdrawal of Fgf4, they will assume more differentiated morphologies and begin 
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expressing markers of the differentiated trophoblast (Tanaka et al., 1998). Like ES cells, 
TS cells also retain the capacity to contribute to normal tissues when reintroduced into 
the early embryo. However, TS cells only contribute to the trophoblast lineages of the 
placenta and not to the fetus itself (Tanaka et al., 1998).  
Permanent cell lines from rat blastocysts (called “rat ES cell-like” cells) have 
been isolated, which like mouse ES cells show compact morphology, and express 
alkaline phosphatase and SSEA1 (Fandrich et al., 2002; Vassilieva et al., 2000). 
Although initially thought to be ES-like, further analysis of these cell lines by the Austin 
Smith group (Buehr et al., 2003) and in our laboratory (Debeb and Binas, unpublished 
results) confirmed that they express the TS cell markers Cdx2 and Eomesodermin but 
lack Oct4 and other ES cell markers. We now call these cell lines “TE-like” and we have 
used them as positive controls when analyzing TS cell genes by RT-PCR (Line B10 in 
Figs. 6B, 12B).  
 
Extraembryonic endoderm (XEN) cells 
XEN cells are the third stem cell type that can be derived from the blastocyst 
(Fowler et al., 1990; Wewer et al., 1982; Notarianni and Flechon, 2001; Kunath et al., 
2005), but appear to represent a stage later than the PrE. XEN cells require feeders or 
feeder-conditioned medium for growth and exhibit round-epithelial interchangeable 
morphologies. Chimeras generated by injection of XEN cells into blastocysts showed 
exclusive contributions to the extraembryonic yolk sac, although predominantly 
  
12 
restricted to the parietal and not visceral yolk sac (Kunath et al., 2005; Shimosato et al., 
2007).  
Our laboratory has, for the first time, isolated XEN cell lines that have the 
features of all XEN derivatives including the XEN-precursor of the ICM. These cell 
lines are the basis of these projects and will be discussed in Chapters II and III.  
 
The Oct4 gene  
Oct4 (also termed Oct3, pou5f1) is a member of the POU transcription factor 
family that are able to activate the transcription of genes bearing cis-acting elements 
containing an octameric sequence (ATGCAAAT)  called the octamer motif, within their 
promoter or enhancer region. The POU domain is a bipartite DNA binding domain 
containing the POU homeodomain and the POU specific domain (Herr and Cleary, 
1995; Ryan and Rosenfeld, 1997). It encodes a protein of 352 amino acids. 
Oct4 was first identified in the extracts of undifferentiated ES and embryonal 
carcinoma (EC) cells (Okamoto et al., 1990; Rosner et al., 1990; Scholer et al., 1990a). 
This suggests an association of Oct4 with the early stages of mouse embryogenesis. Oct4 
has also been identified in other mammalian species including human, bovine, and rat 
(van Eijk et al., 1999; Takeda et al., 1992; Hurt et al., 2004). There is a strong 
conservation in gene sequence and structure in the mammalian Oct4 genes. For example, 
sequence comparisons of the promoter/enhancer regions of human and cow Oct4 genes 
with that of the mouse ortholog revealed 87% and 82% overall protein sequence identity 
and alignment of upstream sequences of human, bovine and mouse promoters revealed 
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four conserved regions (CR1 through CR4) (Nordhoff et al., 2001). Moreover, the 
mammalian Oct4 gene is organized into five exons and is located in the region of the 
major histocompatibility complex (MHC). The Oct4 gene is mapped to chromosome 6 in 
humans (Takeda et al., 1992), to chromosome 17 in mouse (Scholer et al., 1990b; Yeom 
et al., 1991), to chromosome 20 in rat (Hurt et al., 2004) and to chromosome 23 in 
bovine (van Eijk et al., 1999).   
 
Expression of Oct4 
Oct4 is expressed in early mouse embryogenesis and in cells with a totipotent or 
pluripotent differentiation ability (Rosner et al., 1990; Scholer et al., 1990b; Yeom et al., 
1996) (Fig. 3). Oct4 mRNA and protein are present in unfertilized oocytes and the 
protein is localized to the pronuclei following fertilization (Palmieri et al., 1994; Rosner 
et al., 1990). Embryonic expression of Oct4 gene is activated around the eight-cell stage, 
when levels of both mRNA and protein increase significantly in the nucleus (Palmieri et 
al., 1994; Yeom et al., 1991). There is a high and uniform expression of Oct4 mRNA 
and protein in all cells of the embryo through the morula stage (32-64 cells), but the 
levels decrease in the outer cells of the morula when they differentiate and form the TE. 
In contrast, Oct4 expression is maintained in the ICM of the blastocyst (Okamoto et al., 
1990; Rosner et al., 1990). Following implantation, Oct4 expression is restricted to the 
epiblast (also called primitive ectoderm) although it is transiently expressed at high 
levels in cells of the primitive endoderm (also called hypoblast) (Palmieri et al., 1994). 
Oct4 expression is maintained in the epiblast but, as the primitive endoderm 
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differentiates into visceral and parietal endoderm, Oct4 protein levels transiently 
increase and then decrease to undetectable levels. During gastrulation, Oct4 expression 
becomes downregulated in the epiblast and by 7.5 dpc is confined exclusively to newly 
established primordial germ cells (PGCs), precursors of the gametes (Yeom et al., 1996). 
PGCs continue to express Oct4 as they proliferate and migrate to the forming genital 
ridges of the developing fetus.  
 
 
 
 
 
Fig. 3. Oct4 expression pattern in preimplantation and postimplantation 
development. Oct4 is expressed at low levels until the 8-cell stage, when the 
endogenous oct4 is turned on. Black boxes indicate stages that express Oct4 while white 
boxes show little or no Oct4. EPI-P, EPI-precursor; XEN-P, XEN-precursor; PGCs, 
Primordial germ cells; ICM, inner cell mass; TE, trophoectoderm; PrE, primitive 
endoderm. 
 
Oct4 is also expressed in undifferentiated ES and EC cell lines that are derived 
from the ICM and epiblast, respectively. Differentiation of ES and EC cells with retinoic 
acid (RA) or other differentiating agents results in rapid Oct4 downregulation (Scholer et 
al. 1990a, 1990b; Minucci et al., 1996). Oct4 gene expression has also been detected at 
low or undefined levels in adult-derived somatic stem cells (Jiang et al., 2002; Matthai et 
al., 2006) and in tumors (Palumbo et al., 2002; Ezeh et al., 2005; Monk and Holding, 
2001; Suo et al., 2005).   
Oocyte Zygote 4-Cell 8-Cell ICM (EPI-P, XEN-P) Morula 
TE 
Epiblast 
PrE 
PGCs 
Oct4 Upregulation 
Endoderm 
Mesoderm 
Ectoderm 
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Role of Oct4 in pluripotency and development 
The remarkable expression patterns of Oct4 during early embryonic development 
and in undifferentiated ES and EC cell lines suggest an important role of Oct4 in 
maintaining stem cell pluripotency. This importance has been demonstrated by gene 
targeting experiments where Oct4-deficient knock-out embryos developed to the 
blastocyst stage, but failed to make the ICM and were comprised solely of the 
trophoectoderm (Nichols et al., 1998). Moreover, the experimental reduction of Oct4 
levels in ES cells causes the cells to lose pluripotency, and they differentiate into 
trophectoderm in culture (Hay et al., 2004; Niwa et al., 2000; Kim et al., 2002). The 
Oct4 gene controls the pluripotency of stem cells in a quantitative or dosage-dependent 
manner. This was elegantly demonstrated in ES cells by Niwa et al. (Niwa et al., 2000) 
using an inducible Oct4 expression coupled to homologous recombination of the 
endogenous Oct4 gene. In this study, a 50% decrease in expression of the endogenous 
Oct4 levels triggered trophoectodermal differentiation, whereas a 50% increase initiated 
upregulation of primitive endoderm and mesoderm markers. This confirms the findings 
of Palmieri et al. (Palmieri et al., 1994) who described Oct4 protein expression to appear 
higher in the newly forming primitive endoderm than that seen in the ICM population of 
murine blastocysts. In accord with this, a recent finding showed that a transient increase 
of Oct4 is involved in cardiac specification of the epiblast (Zeineddine et al., 2006).  
The dose dependent effect of Oct4 was also observed to dictate the oncogenic 
potential of ES cells (Gidekel et al., 2003); high levels increase the malignant potential 
of ES cell-derived tumors while Oct4 inactivation induced regression of the malignant 
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component (Gidekel et al., 2003). This suggests that Oct4 plays a significant role in the 
malignant behavior of ES cells. Moreover, ectopic expression of Oct4 resulted in 
dysplastic growths in epithelial tissues by inhibiting cellular differentiation in a manner 
similar to that in ES cells (Hochedlinger et al., 2005).  
In addition to its role in the maintenance of pluripotency of stem cells, Oct4 was 
also found to be important in keeping the viability of the mammalian germline (Kehler et 
al., 2004). Using conditional gene targeting, primordial germ cells lacking Oct4 
expression have been shown to undergo apoptosis rather than differentiation to TE. 
Moreover, Oct4 was found to be crucial in inducing pluripotency in a recent outstanding 
study by Yamanaka and Takahashi (Yamanaka and Takahashi, 2006) who engineered 
ES-like cells from normal mouse skin cells. In this study, the researchers introduced four 
gene-transcription factors (Oct4, Sox2, Klf4 and c-myc) into fibroblast cells originating 
from mouse skin, and specifically selected those cells that, in response to these factors, 
expressed genes indicative of a pluripotent state. If this method can be translated to 
humans, patient-specific stem cells could be made without the use of donated eggs or 
embryos (Yamanaka and Takahashi, 2006; Yamanaka, 2007). This remarkable work was 
validated by other teams (Okita et al., 2007; Maherali et al., 2007; Wernig et al., 2007). 
 
Role of Oct4 in transcription 
Oct4 activates and represses transcription of different target genes. The genes 
encoding fibroblast growth factor 4 (Fgf4), the Osteopontin adhesion molecule (OPN), 
and the acidic zinc finger gene Rex1 provide models of Oct4-dependent positive 
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regulation while the repression of Cdx2 and HCG a and b genes are examples of a 
negative regulation. 
Fgf4 is expressed in the ICM and is essential for the survival of postimplantation 
mouse embryos (Feldman et al., 1995). Fgf4 is a stem cell-specific growth factor, and 
has an enhancer element located within the 3'-untranslated region (UTR) of the gene, 
which is responsible for its stem cell-specific expression (Curatola and Basilico, 1990). 
This enhancer contains an octamer motif adjacent to a binding site to which Oct4 and 
Sox2 bind cooperatively to activate transcription synergistically (Yuan et al., 1995). In 
the absence of Sox2, Oct4 is not sufficient for Fgf4 enhancer activity. Targeting of the 
Oct4 gene demonstrated that Oct4-null embryos either do not express or have a reduced 
expression of Fgf4 (Nichols et al., 1998). Stimulation by Fgf4 increases the formation of 
diploid trophoblastic cells from outgrowths of Oct4-null embryos in culture. This result 
confirms the notion that Fgf4 acts as a paracrine factor, sustaining the proliferation of 
trophoblast cells (Tanaka et al., 1998). Addition of Fgf4 to the culture medium, however, 
does not rescue the lethality of the Oct4 deficient embryos suggesting the requirement 
for expression of other genes (like Sox2) transactivated by Oct4. 
The OPN gene, which encodes an extracellular matrix component involved in 
cellular migration, is weakly expressed in the ICM and ES cells and is upregulated in 
primitive endodermal cells prior to their differentiation to parietal or visceral endodermal 
cells (Botquin et al., 1998; Palmieri et al., 1994). Botquin et al. (Botquin et al., 1998) 
found that retinoic acid treatment of F9 EC cells, which are usually used as a model for 
differentiation of the primitive endoderm, results in a transient increase of Oct4, 
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paralleled by an increased expression of OPN. A search for Oct4 potential binding sites 
within the cis-regulatory sequences of the OPN gene identified a novel palindromic 
sequence named palindromic-oct-regulatory-element (PORE) within the first intron of 
OPN. This sequence contains an ATGCAAAT octamer motif and an inverted half-site, 
CAAAT, separated by two nucleotides to which Oct4 binds in vivo as a monomer and a 
homodimer (Botquin et al., 1998).  
The Rex1 gene is a developmentally regulated acidic zinc finger gene (Zfp-42) 
and a well recognized marker for the pluripotent state of both ES cells and EC cells 
(Rogers et al., 1991). Both EC and ES cells can be induced to differentiate into primitive 
endoderm-like cells by treatment with retinoic acid with the downregulation of 
pluripotency markers such as Rex1 (Rogers et al., 1991; Ben-Shushan et al., 1998). The 
Rex1 promoter contains an octamer motif (ATTTGCAT) at position -220 that is required 
for its activity in undifferentiated F9 cells and is involved in RA-mediated 
downregulation (Hosler et al., 1993; Rogers et al., 1991). This octamer motif is a binding 
site for octamer transcription factor members of the POU domain family of DNA 
binding proteins such as Oct4. Subsequent analysis has demonstrated that Oct4 can 
regulate the activity of Rex1 promoter through this octamer motif in a dose dependent 
manner (Ben-Shushan et al., 1998). In addition to the octamer motif, a positive 
regulatory element, which is located immediately 5’ of the octamer motif, was identified 
in the Rex1 promoter. Mutations in this element severely compromised the activity of 
the Rex1 promoter in F9 cells suggesting that this element plays a key role in the 
activation of Rex1 gene transcription (Ben-Shushan et al., 1998). Recently, Nanog (a 
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homeodomain protein known for its role in maintaining pluripotency) was found to be a 
transcription activator for the Rex1 promoter (Shi et al., 2006). The knockdown of 
Nanog in ES cells resulted in a reduction of Rex1 expression, whereas forced expression 
of Nanog in P19 EC cells stimulated Rex1 expression. Serial deletion studies mapped 
the Nanog-responsive element between -187 and -286 of the Rex1 promoter. 
Furthermore, Sox2, not Oct4, appeared to cooperate with Nanog in upregulating Rex1 
although both Oct4 and Sox2 can tranactivate Rex1 promoter (Shi et al., 2006).  
Oct4 also functions as a repressor of some specific target genes. For example, 
Oct4 represses the caudal-related homeobox transcription factor Cdx2, which is 
expressed in the TE lineage in the early stage embryos (Niwa et al., 2000; Strumpf et al., 
2005). Cdx2 becomes expressed when Oct4 expression is suppressed (Niwa et al., 2000), 
and Oct4 expression becomes suppressed when Cdx2 is force-expressed (Niwa et al., 
2005) in ES cells. In both cases, the result is a phenotypic change towards the TE 
lineage. Conversely, genetic lack of Cdx2 prevents downregulation of Oct4, and the TE 
lineage can not form (Strumpf et al., 2005; Niwa et al., 2005). Likewise, the murine Oct4 
has been found to silence transcription of both human HCG a and b genes required for 
implantation and the maintenance of pregnancy (Liu and Roberts, 1996; Liu et al., 
1997). Both HCG subunits are first expressed as trophectoderm begins to differentiate, 
when the Oct4 gene is normally downregulated. This suggests that their expression is 
normally repressed by Oct4, and become activated as Oct4 is downregulated.  
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Regulation of Oct4 gene expression 
The regulatory control of the Oct4 expression has been studied extensively in 
stem cells and in developing embryos because the specific expression of Oct4 during 
early mouse development is required for the maintenance of pluripotent cells. 
Transgenic analysis of Oct4 expression in the developing mouse embryo was carried out 
using a LacZ reporter gene linked to various regions of Oct4 upstream sequences (Yeom 
et al., 1996). An 18-kb genomic fragment was found to correctly reproduce the 
endogenous pattern of Oct4 expression in both preimplantation and postimplantation 
embryos. Deletion analysis demonstrated that Oct4 gene expression is dependent on at 
least three upstream cis-regulatory regions: the minimal/proximal promoter, the 
proximal enhancer and the distal enhancer, based on their position with respect to the 
transcription initiation site (Fig. 4) (Yeom et al., 1996). 
 
 
 
 
Fig. 4. Genomic structure of the Oct4 gene known regulatory elements. The gene is 
divided into five exons, depicted as black boxes. The identified upstream regulatory 
regions include the proximal promoter, proximal enhancer and distal enhancer. 
 
The Oct4 proximal promoter, located within the first 250 bp of the transcription 
initiation sites, is a TATA-less promoter containing a cluster of overlapping binding sites 
recognized by specific DNA binding proteins. Among these is a GC box representing a 
high-affinity site for Sp1/Sp3 transcription factors that mediate Oct4 minimal promoter 
Site       2A                             1A   1B        1                       2    3  4      5 
             Distal               Proximal          Proximal 
          enhancer                   enhancer          promoter   OCT4 
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activity (Sylvester and Scholer, 1994; Okazawa et al., 1991). Mutation of the GC box in 
the Oct4 promoter abolishes expression in both ES and EC cells (Minucci et al., 1996).  
The proximal enhancer, located 1.2 kb upstream of the transcription start site, is 
known to mediate P19 EC cell-specific expression and RA-induced Oct4 
downregulation (Okazawa et al., 1991). In the developing embryo, the activity of this 
enhancer is limited to the epiblast (Yeom et al., 1996). In undifferentiated cells of the 
preimplantation embryo, in ES cells and in F9 EC cells, the activity of the proximal 
enhancer is very low (Yeom et al., 1996; Minucci et al., 1996). The enhancer contains a 
cis-acting element which responds to RA repression, although it does not encompass a 
recognizable RA receptor binding site (Okazawa et al., 1991). This element can be 
subdivided into two sites (1A and 1B) (Fig. 4). Both sites bind distinct factors in vitro 
(Okazawa et al., 1991), but only site 1A is occupied in vivo in undifferentiated ES and 
EC cells (Minucci et al., 1996). This site is GC-rich and related to the consensus Sp1 
binding site in the promoter (Minucci et al., 1996).  
The distal enhancer, located ~2 kb upstream of transcription start sites, is active 
in undifferentiated cells of the preimplantation embryo and, later in development, is also 
responsible for the specific expression of Oct4 in PGCs (Yeom et al., 1996). ES and EG 
cells also require the distal enhancer for Oct4 expression. Thus, the activity of this 
enhancer is restricted to totipotent and pluripotent cell types. Within the distal enhancer 
is a site 2A, which is similar to, but in the opposite orientation of site 1A of the proximal 
enhancer (Fig. 4). In vivo, genomic foot-printing demonstrated that site 2A is also 
occupied in undifferentiated ES and EC cells (Minucci et al., 1996). 
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Rationale 
By the late blastocyst stage, the mammalian conceptus consists of three 
fundamental tissue lineages: the placental trophoblast that is derived from the TE, the 
fetus proper that is derived from the EPI, and the yolk sac endoderm that is derived from 
the PrE. During the first embryonic lineage choice, the outer cells of the mammalian 
morula become committed towards the TE lineage. The remaining cells, called the ICM, 
give rise to the EPI and PrE cells (the second embryonic lineage choice) by the late 
blastocyst stage. It has previously been thought that the ICM cells of the early blastocyst 
are homogenous population of bipotential cells each with the ability to become both EPI 
and PrE. But, recently it was discovered that the ICM is heterogeneous and consists of 
two closely related, anatomically indistinguishable groups of cells: the committed EPI-
precursor and the committed XEN-precursor cells (Chazaud et al., 2006; Kurimoto et al., 
2006). The committed EPI-precursor gives rise to the embryo proper while the 
committed XEN-precursor gives rise to the yolk sac endoderm, a tissue that plays a 
major role in the nutritive support of the embryo and is required for several inductive 
events, such as anterior patterning and blood island formation (Jollie, 1990; Baron, 2003; 
Rossant, 2007).  
Cell lines from early embryonic lineage precursors are powerful tools for the 
study and manipulation of development and differentiation (Rossant, 2007). These 
resulting insights, as well as the stem cell lines themselves, play increasingly important 
roles in regenerative medicine, reproduction, and cancer research. Permanent cell lines 
that represent the EPI-precursor (called ES cells) and the TE lineage (called TS cells) 
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have been established and characterized (Evans and Kaufman, 1981; Martin, 1981; 
Tanaka et al., 1998). However, cell lines from the third stem cell type that represents the 
ICM-stage XEN (XEN-precursor) lineage has not been described. Mouse XEN cell lines 
published recently (Kunath et al., 2005) do not express Oct4 and are biased towards the 
PE in vivo, and thus do not represent the XEN-precursor. Our laboratory has isolated 
cell lines from rat blastocysts that have XEN morphology, and preliminary results 
showed these lines stably express Oct4, a key ICM marker. 
The hypothesis of our investigation was that these rat XEN cells represent the 
XEN-precursor of the ICM. In the first chapter, we offer compelling evidence that our 
rat XEN cells stably and reproducibly maintain the molecular signature of the ICM-stage 
XEN-precursor (Oct4+ Gata6+ SSEA1+Nanog- Cdx2- Sox2-), incorporate into the ICM 
and show the full XEN-precursor differentiation potential in vitro and in vivo. In the 
second chapter, we investigated the regulation of Oct4 gene expression in the rat XEN 
cells and compared it to the regulation in ES cells. We present data demonstrating that a 
novel enhancer drives Oct4 gene expression in rat XEN cells and that there is differential 
regulation in these cells and mouse ES cells. 
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CHAPTER II 
 
LINEAGE MARKER EXPRESSION IN RAT YOLK SAC ENDODERM STEM 
CELL LINES  
 
Overview 
The ICM of mammalian embryos consists of two intermingled, short lived cell 
types: epiblast (EPI)-precursor and extraembryonic endoderm (XEN)-precursor. In vitro 
the EPI-precursor cells are represented by the well-studied ES cells but cell lines 
representing the XEN-precursor stage remain elusive. Our laboratory has recently 
isolated rat XEN cell lines that we hypothesize represent the XEN-precursor stage since 
they express Oct4. The data presented here provide strong evidence for our hypothesis as 
our rat XEN cell lines exhibited the molecular signature (Oct4+Gata6+Nanog-Cdx2-) 
and differentiation potential (primitive/visceral and parietal XEN) expected from the 
XEN-precursor cells. These findings establish the XEN-precursor as a self-renewable 
entity and provide a model of early XEN differentiation. 
 
Introduction 
Cell lines isolated from mammalian preimplantation-stage embryos play key roles 
in the study of embryogenesis, differentiation, and cellular reprogramming, work that is 
considered important for regenerative medicine, reproduction, cancer research and 
species conservation. Known blastocyst-derived stem cell lines include ES cells (Evans 
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and Kaufmann, 1981; Martin, 1981), TS cells (Tanaka et al., 1998), XEN stem cells 
(Kunath et al., 2005), and some less-defined rat blastocyst stem cells that seem to be 
extraembryonic (Buehr et al., 2003; Fandrich et al., 2002). Transplantation and 
expression profiling experiments revealed that the ICM of early mouse embryos is not 
homogeneous as previously thought, but consists of two closely related, anatomically 
indistinguishable groups of cells (Chazaud et al., 2006; Kurimoto et al., 2006): (i) the 
committed epiblast precursor (EPI-precursor) that gives rise to the extraembryonic 
mesoderm and the embryo proper; (ii) the committed extraembryonic endoderm 
precursor (XEN-precursor) that gives rise to the yolk sac endoderm. The yolk sac 
provides essential roles in nutrition, axial patterning, and hematopoiesis (Jollie, 1990; 
Baron, 2003; Rossant, 2007). 
The well-known mouse ES cell lines (Evans and Kauffman, 1981; Martin, 1981) are 
now thought to be the in vitro correlate of the EPI-precursor (Chazaud et al., 2006). By 
contrast, cell lines analogously representing the XEN-precursor have not yet been 
described, and therefore the nature of the XEN-precursor and its relationship to EPI-
P/ES cells are poorly understood. The presently known XEN cell lines (Kunath et al., 
2005) cannot efficiently contribute to the visceral yolk sac lineage and seem to exhibit 
none of the features that collectively define the ICM stage (i.e. both EPI-precursor and 
XEN-precursor), most noticeably expression of the pluripotency marker Oct4 (Chazaud 
et al., 2006; Kurimoto et al., 2006).  It has, however, been observed that mouse ES cells 
carrying a null mutation of the Nanog gene become committed to the XEN lineage while 
maintaining the ability to proliferate and express the gene encoding Oct4 (Mitsui et al., 
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2003), a key transcription factor whose mRNA and protein is expressed in all cells of the 
ICM (Chazaud et al., 2006; Kurimoto et al., 2006). This suggests that just like their EPI-
precursor siblings, XEN-precursor cells can exist as a distinct, self-renewing entity in 
vitro. Here, we present wild-type rat blastocyst-derived cell lines that show the lineage 
marker profile and differentiation potential expected from the XEN-precursor cells.  
 
Materials and methods 
Derivation and maintenance of XEN cell lines 
 Derivation of cell lines was performed by Dr. B.Binas (except for CX5- that was 
isolated by J.Epple-Farmer). Primary mouse and rat embryo fibroblasts (PMEFs and 
PREFs) were derived by standard methods (Nagy et al., 2002). D3 mouse ES cells 
(Doetschman et al., 1985) were maintained on mitomycin-treated PMEFs in the presence 
of 1000 u/ml LIF. For the derivation of rat XEN cell lines, 4.5 days-post-coitum (dpc) 
blastocysts were plated into Nunc 4-well dishes onto mitomycin (10 µg/ml)-treated 
embryo feeders in DMEM (with glutamine and sodium pyruvate) containing 15% fetal 
calf serum (ES-qualified) and 1,000 u/ml LIF at 370C and 5% CO2. Lines CX1 (rat strain 
WKY), CX2 (strain BDIX), and CX5 (WKY) were derived, respectively, on PREF, 
PMEF, and Li1, a permanent rat fibroblast feeder cell line that was obtained by 
spontaneous immortalization of PREFs from a day-11 rat embryo (strain SD). In about 2 
weeks after plating, the blastocyst outgrowths had completely converted into XEN, 
which was mechanically transferred into a new well. The rat XEN cell lines were 
maintained in the same medium used for derivation, and transferred every 2-3 days by 
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trypsinization (0.25% trypsin-EDTA) onto mitomycin-treated Li1 cells (~50,000 Li1 
cells/cm2). After derivation, the cells have been growing permanently without slowing 
down for >50 passages and the experiments described here were mostly performed 
between passages 30 and 40. For the derivation of mouse XEN cell lines, 3.5 dpc 
blastocysts from NMRI strain (CX3, CX4) and strain BalbcxB6 F1 (CX6) were plated 
onto mitomycin-treated PMEFs in DMEM containing 15% serum. The mouse XEN cell 
lines were then routinely maintained on PMEFs by trypsinization. In all experiments 
mouse ES cells (line D3) were used for comparison because rat ES cells have not yet 
been derived. 
 
RNA extraction, reverse transcription and RT-PCR 
Total RNA was extracted from whole culture cells using TRIZOL (Invitrogen) 
following the manufacturer's instructions and the concentration was measured using a 
NanoDrop spectrophotometer (NanoDrop Technologies, Wilmington, DE). The RNA 
was then subjected to DNaseI treatment using a DNA-free kit (Ambion, Austin, TX) at 
37°C for 30 minutes to remove any contaminating genomic DNA. 2 µg of total RNA 
was used for reverse transcription (RT) reaction. To extract RNA from microsamples, 
the RNeasy microkit (Qiagen, Valencia, CA) that included DNase treatment was used. 
From these samples, half of the eluted RNA (~6µl) was used for the RT.  The RT 
reaction was performed with random hexamers using the first strand cDNA synthesis 
Superscript II kit (Invitrogen) in a total volume of 20 µl according to the procedure 
provided by the manufacturer. After the RT reaction, the enzyme was denatured at 70°C 
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for 15 minutes. "No- RT" control (RNA) was also made from each sample to confirm the 
absence of contaminating genomic DNA.  
Equal amounts of the cDNA samples were subjected to PCR amplification in a 
25 µl reaction volume using 2.5 units of Taq DNA polymerase, 10x PCR buffer, 2.5 mM 
MgCl2, 200 µM dNTP, 0.2 µM gene-specific forward, and 0.2 µM reverse PCR primers. 
Primers were designed using the Primer3 software of the Whitehead Institute 
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi). In order to amplify the 
genes with equal efficiency from the rat and mouse cell lines, we aligned the sequences 
for each gene and designed dual-specific primers from the homologous regions. Hprt 
was used as an internal control. By using species-specific Hprt primers that distinguish 
mouse and rat, we excluded cross contaminations between the rat and mouse lines. The 
sequences of each specific primer set, including their product size and accession 
numbers are listed in Table 1. Cycle conditions for the PCR were as follows: 94°C for 1 
minute; 25–35 cycles of 94°C for 30 seconds, 60°C for 30 seconds and 72°C for 1 
minute; 72°C for 5 minutes. The PCR products were visualized on a 1.5% agarose gel 
containing ethidium bromide.  
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Real-time PCR was performed in duplicate in a volume of 25 µl (containing 5 µl of 
10x-diluted cDNA template, 1 µl (10 µm) of each primer, 0.5 µl Rox dye and 12.5 µl of 
SYBR Green PCR supermix (Invitrogen). The products were detected with the ABI 
Prism 7700 sequence detection system (Applied Biosystems). Fluorescence was 
quantified as a Ct value with Oct4 gene expression levels calibrated using Hprt as an 
internal control. The differences between the mean Ct values of the gene of interest 
(Oct4) and the housekeeping gene (Hprt) were denoted (delta-Ct) and the difference 
between delta-Ct and the Ct value of the calibrator sample (ES cells) was labeled delta-
delta-Ct. The log2(delta-delta-Ct) gave the relative quantitation value of the Oct4 gene 
expression with ES cell expression designated as one. The cycling conditions were as 
follows: 50°C for 2 min; 95°C for 10 min; 40 cycles at 94°C for 15 sec, 60°C for 30 sec , 
and 72°C for 30 seconds. Control wells containing SYBR Green PCR master mix and 
primers without sample cDNA emitted no fluorescence after 40 cycles. 
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Table 1. List of primers used in this study 
 
 
 
Primers (5’3’) 
 
Gene Bank Accession No. 
 
 
Gene Forward Reverse 
 
Product 
size Mouse Rat 
Oct4    NM_013633 XM_228354 
   Mouse-specific ggcgttctctttggaaaggtgttc actcgaaccacatccttctct 314   
   Rat-specific ggtggaggaagctgacaacaac ggcaatgctagtgatctgctgc 172   
   Dual-specific gagggatggcatactgtggac ggtgtaccccaaggtgatcc 272   
Nanog tatcccagcatccattgcag gtcctccccgaagttatggag 252 AB126939 AB162852 
Sox2 ccaagacgctcatgaagaagg   ctgatcatgtcccggaggtc    478 NM_011443 XM_574919 
Fgf4 tctactgcaacgtgggcatc tggtccgcccgttcttac 285 NM_010202 NM_053809 
Rex1 tggagtacatgacaaaggggac   gcagccatcaaaaggacacac    509 NM_009556 XM_224882 
Gata6 gccgggagcaccagtaca gtgacagttggcacaggacag 419 AF179425 NM_019185 
Hnf4  gtgctgctcctaggcaatgac cttgacgatggtggtgatgg 651 NM_008261 NM_022180 
FoxA2 agccccaacaagatgctgac tggttgaaggcgtaatggtg 602 NM_010446 NM_012743 
Ihh cctgtcagctgtaaagccagg   ggagcataggacccaaggg     336 NM_010544 AF175209 
LamininB actacaccacgggccacaac    gcccaggtaattgcagacacac 440 NM_008482 XM_216679 
Dab2 ccacaggacaacctgcagtc    gccacagatgtggtaggacac   325 BC016887 NM_024159 
Sparc attgcaaacatggcaaggtg gccagtggacagggaagatg 474 NM_009242 NM_012656 
Cdx2 gcgaggactggaatggctac tccttggctctgcggttc 499 NM_007673 NM_023963 
Eomesodermin cggcaaagcggacaataac gttgtcccggaagcctttg 361 NM_010136 AY457971 
Placental lactogen ctgcttccatccatactccaga gacaactcggcacctcaaga 410 XM_225307 NM_172156 
Hprt    NM_013556 NM_012583 
    Mouse-specific gcttgctggtgaaaaggacctct ggaaatcgagagcttcagactcgtc 584   
    Rat-specific gcttgctggtgaaaaggacctct ccacaggactagaacgtctgctagttc 251   
    Dual-specific cagtcccagcgtcgtgattag atccagcaggtcagcaaagaac 229   
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Northern blot  
Northern blotting was performed using established procedures without significant 
modifications (Sambrook and Russell, 2001). Total RNA was isolated with TRIZOL 
(Invitrogen), and 5ug per lane were electrophoresed. The gels were blotted onto Hybond 
(Amersham) membranes, and hybridizations were performed using probes that were 
produced by RT-PCR and labeled with 32P-dCTP by the random priming procedure.  
The sources of the probe cDNAs were ES cells (Nanog) or rat XEN cells (Gata6 and 
Oct4), using the primers indicated in Table 1 for Nanog and Gata6 or primer pair 
ggagggatggcatactgtgg and accagggtctccgatttgc for Oct4. rRNA was used to ensure equal 
loading of RNA samples.  
 
Western blot 
Protein extraction and western blotting were carried out as described in 
Sambrook and Russel (2001). Cells were trypsinized, centrifuged, suspended in PBS and 
pelleted by centrifugation. Pellets were then resuspended in 10% SDS, and boiled at 
950C for 10 min. Protein concentration was determined using the BCA kit (Pierce) and 
equal amounts of protein samples (50µg/lane) were separated through 10% 
polyacrylamide by SDS-polyacrylamide gel electrophoresis. The gel was equilibrated in 
transfer buffer and electroblotted onto nitrocellulose filters (Biorad) for 1 hr at 350mA or 
overnight at 90mA.  The membranes were then blocked with TBS/Tween/5% milk 
powder for 1 hr at room temperature. They were then incubated for 2 hrs at room 
temperature with a monoclonal anti-oct4 antibody (Santa Cruz) at a dilution of 1:200. 
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After washing the membranes 3x (each 5min) with TBST, they were incubated for 1 hr 
with alkaline phosphatase-conjugated goat anti-mouse secondary antibody (Santa Cruz) 
diluted at 1:1000. After 3x washing with TBST, the blots were developed using the 
Western Blue substrate (Promega).   
 
Immunocytochemistry 
 Cells were seeded into Nunc 4-well plates at regular passaging density or at low 
density (100 cells/well). At the time point of interest, immunocytochemistry was 
performed at room temperature. The wells were washed twice with PBS, fixed in 4% 
paraformaldehyde (10-15 minutes) and rinsed 3x with PBS. For intracellular antigens 
(Oct4, Gata6), the cells were then permeabilized with 0.2% Triton X-100 in PBS (15-20 
minutes) and rinsed 3x with PBS. Cells were blocked with 5% goat serum (Santa Cruz) 
in PBS (1 hr), incubated with primary antibodies overnight, rinsed 3x with 1% goat 
serum, and incubated with the secondary antibody conjugated to either FITC, TR or 
TRITC for 1 hr in the dark. For dual-color immunofluorescence, species-specific 
secondary antibodies conjugated with FITC or TR was used. After secondary antibody 
incubation, the cells were washed 3x with 1% goat serum, incubated with 1 µg/ml of 
Hoechst dye in PBS, and photographed under epifluorescence. The antibodies and their 
dilutions are listed in Table 2.  
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Table 2. List of antibodies used in this study 
Antigen Primary antibody  
and dilution* 
Secondary antibody and dilution* 
Oct4 SC-5279; 1:100 Goat anti-mouse IgG-FITC, 1:200, SC-3699 
Oct4 SC-9081, 1:200 Goat anti-rabbit IgG-TR, 1:300, SC-3842 
Gata6 SC- 9055, 1:200 Goat anti-rabbit IgG-TR, 1:300, SC-3842 
SSEA-1 DSHB MC-480, 1:500 Goat anti-mouse IgG-FITC, 1:200, SC-3699 
SSEA-3 DSHB MC-631, 1:100  Goat anti-mouse IgG-TRITC, 1:100, Invitrogen  
81-6514 
Laminin B2 DSHB D18, 1:400  Goat anti-mouse IgG-FITC, 1:200, SC-3699 
Collagen IV DSHB M3F7, 1:200 Goat anti-mouse IgG-FITC, 1:200, SC-3699 
* SC, Santa Cruz Biotechnology; DHSB, Developmental Studies Hybridoma Bank, University of Iowa. 
 
Alkaline phosphatase stain 
Alkaline phosphatase staining was performed as described (Nagy et al., 2002). 
Briefly, cells were grown overnight in 4-well plates, were fixed in 4% paraformaldehyde 
for 15 min and then were washed three times with PBS. About 300µl of alkaline 
phosphatase staining solution, consisting final concentrations of 25mM Tris-maleate (pH 
9.0), 0.4mg/ml   -naphtyl phosphate, 1mg/ml Fast-Red TR salt, and 8mM MgCl2, was 
added to each well and incubated for 30 min to 1 hr at room temperature. After removing 
the solution the cells were washed with PBS and photographed with IPX70 microscopy.  
 
Vector production and GFP labeling of rat XEN lines 
Recombinant lentivirus vector and packaging constructs were generously 
provided from Dr. David Baltimore (Caltech). The vector construct consists of a human 
immunodeficiency virus (HIV)-based self-inactivating (SIN) replication-defective 
lentivirus transfer vector, pFUGW, expressing a green fluorescent protein (GFP) reporter 
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gene driven by the human ubiquitin-C promoter (Lois et al., 2002). The helper plasmid 
constructs are the packaging plasmid, pCMV  R8.91, and the envelope plasmid, pMD.G 
encoding VSV-G. For virus production, 293T cells were seeded at 2 x 106 cells per 100-
mm dish the day before transfection, and each dish was co-transfected with 10 µg of 
pFUGW, 10 µg of pCMV  R8.91 and 6µg VSV-G plasmid using lipofectamine 2000 
(Invitrogen) following manufacturer’s instructions. After 24 hrs of incubation, cells were 
gently washed 2x with serum-free media. The cells were then incubated with media 
containing serum. The culture supernatants containing virus particles were harvested 24 
hrs later, centrifuged at 500 g for 5 min to remove cell debris and filtered through a 
0.45µM pore-size filter. The supernatant was concentrated using Centricon Plus-20 
ultrafiltration device (Millipore, Bedford, MA) according to the manufacturer's 
instructions. The concentrated virus was stored at -80°C. The titers of vector stocks were 
determined by serial dilutions on 293T cells.  
For transduction, rat XEN cells were seeded in 4-well plates (Nunc) at a density 
of 5 x104 cells per well and incubated overnight. The media was changed 2 hrs before 
transduction. Transductions were carried out in the presence of 8 µg of Polybrene 
(Sigma) per ml of media at MOI of 1. After incubation at 37°C for 24 hrs, the 
transduction medium was replaced with fresh DMEM containing serum. The percentage 
of cells exhibiting GFP fluorescence was quantified using fluorescence microscope. The 
cells were then expanded and sorted for GFP before injections.  
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Microinjection experiments 
These experiments were done in the laboratory of our collaborators, Drs. 
Iannaccone and Galat, at Northwestern University, Chicago. All cells were manipulated 
in cell culture media mixed with an equal volume of M2 and kept on ice before injection. 
Micromanipulations were performed with a Leica system essentially as described 
(Stewart, 1993; Iannaccone and Galat, 2002). For the in vitro experiments, 1-3 rat XEN 
cells were injected into rat or mouse blastocysts or morulae, or the cells were aggregated 
with, or sandwiched between, rat morulae freed from the zona pellucida by acid Tyrode 
solution (Sigma). Groups of 3-10 embryos were then cultured in 30 µl-drops of KSOM 
(Specialty Media) under pre-equilibrated mineral oil (Sigma) for 24-48 hrs at 37o C in 
5% CO2. For the in vivo experiments, 3-5 rat XEN cells were injected per blastocyst, 
followed by transfer into the uteri of pseudo-pregnant females, and the conceptuses were 
recovered and dissected at 6.5-10.5 dpc. After in vitro culture or in vivo development, 
the injected GFP-labeled rat XEN cells or their offspring were located by fluorescence 
microscopy and confocal images acquired using a Zeiss LSM 510 META Laser 
Scanning Microscope System (Thornmood, NY).  
 
Results 
Cultured rat XEN cells express Oct4. When rat blastocysts were explanted on 
mitotically inactivated primary embryo fibroblast feeders, smooth, compact outgrowths 
grew rapidly and morphologically resembled ES cell colonies. The expression of Oct4 
mRNA was followed in the resulting outgrowths by RT-PCR. Oct4 mRNA was lost in 
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the outgrowths within 6 days, but after ~10 days, the outgrowths stopped enlarging and 
abruptly converted into cells with the characteristic XEN morphology and 
simultaneously started re-expressing Oct4 mRNA at a level comparable to that in 
blastocysts (Fig. 5). 
 
 
 
 
Fig. 5. Loss and re-emergence of Oct4 expression in rat blastocyst outgrowths. 
Individual outgrowths were analyzed at the indicated culture days by RT-PCR for Oct4 
(rat-specific primer pair) and hprt (housekeeping gene). Day 0= blastocyst. The 
outgrowths showed compact, ICM-like morphology before day 10, but XEN 
morphology thereafter. W, water control. (Contributed by Dr. B. Binas) 
 
Intrigued by the expression of the ICM marker Oct4 which was not studied in 
previously isolated rat XEN cell lines (Notarianni and Flechon, 2001; Ouhibi et al., 
1995) and is absent from mouse XEN cell lines (Kunath et al., 2005), three rat XEN cell 
lines were established (CX1, CX5 - strain WKY; CX2 –strain BDIX). For comparison, 
three mouse XEN lines (CX3, CX4 - strain NMRI; CX6 – strain BalbcxB6 F1) were 
isolated; all strains were randomly selected. 
All rat XEN lines and the mouse ES cells, but neither the mouse XEN lines nor 
rat TE-like cells expressed Oct4 mRNA. Despite this, all XEN cell lines showed the 
characteristic XEN morphology (Fig. 6A) and expressed the parietal endoderm markers, 
laminin B and Sparc (Fig. 6B). However, the rat XEN cells expressed higher levels of 
the pan-XEN marker Gata6 and of the VE markers, Dab2 and Foxa2. Also, rat XEN and 
Oct4 
HPRT 
W 8 7 11 
Days after blastocyst explantation 
0 4 6 13 
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mouse ES cells, but not mouse XEN cells, expressed the TE marker Eomesodermin and 
ICM/ES marker Rex1. However, the TE markers Cdx2 and placental lactogen, and the 
ES markers Nanog, Fgf4, and Sox2 were absent from the rat XEN cells (Fig. 6B). 
Since Oct4 gene expression in XEN cells has not been reported before and is the 
central finding underlying our study, we validated this result with several independent 
methods. Using dual-specific (rat=mouse) primers, we compared the Oct4 mRNA levels 
of whole cultures and arbitrarily picked microsamples (<500 cells) with mouse ES cells 
(=100%) by qRT-PCR. Normalized to HPRT mRNA, the Oct4 mRNA contents ranged 
from 30-84% in whole cultures and from 19-210% in microsamples (Table 3). 
Importantly, Table 3 also shows that high oct4 mRNA expression is not limited to one 
XEN cell line or rat strain, since independently derived XEN cell lines from the same 
strain (CX5, strain WKY) and another arbitrarily chosen rat strain (CX2, BDIX) also 
expressed oct4 mRNA at significant levels. 
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Fig. 6. Cultured rat XEN cells express ICM and XEN markers. (A) Phase contrast 
photo showing characteristic morphology of rat XEN cells growing on rat embryo 
fibroblast feeder. Colonies obtained by low-density plating typically contained round, 
refractile cells at their fringes and epithelial cells inside. (B) RT-PCR analysis showing 
that cultured rat XEN cells exhibit a mixed embryonic lineage marker profile. Rat XEN 
cells (lines CX1, CX2, CX5) were compared with mouse XEN cells (lines CX4, CX6), a 
mouse ES cell line (D3), a TE-like rat cell line (B10), a rat embryo fibroblast cell line 
(Li1) used as feeder for rat XEN cells, and primary mouse embryo fibroblasts (MEF) 
used as feeders for mouse XEN and ES cells. Note that line B10 was previously 
suspected to be ES-like (Fandrich et al., 2002) but is in fact rather TE-like, as shown in 
this figure and in line with findings by Buehr et al. (2003). For Gata6, Foxa2, and Dab2, 
two dilutions of the RT reaction were subjected to PCR for semi-quantitative 
comparison. See Table 1 for primer sequences. 
Rat hprt 
Oct4 
Rex1 
Sox2 
Nanog 
Fgf4 
Gata6 
Foxa2 
Dab2 
Hnf4 
Ihh 
Lam.B 
Sparc 
Eomes 
Cdx2 
Pl.lact. 
Mouse hprt 
Dual hprt 
-RT 
CX
1 
CX
5 
CX
2 
CX
4 
CX
6 
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1 
M
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B1
0 
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Table 3. Quantitative RT-PCR for Oct4 expression in XEN cells 
 
 
We then chose the rat XEN cell line CX1 for closer examination of Oct4 gene 
expression. Northern blotting showed that the Oct4 mRNAs in rat XEN and mouse ES 
cells were of the same length; in agreement with the qRT-PCR, the average rat XEN 
Oct4 mRNA level was somewhat lower than in ES cells (Fig. 7A). The figure also 
confirms that along with Oct4, rat XEN cells express Gata6 and lack Nanog, i.e. show 
the hallmark expression pattern of the XEN-precursor (Chazaud et al., 2006). In order to 
examine whether the Oct4 mRNA is translated into a protein, we performed western 
blotting. Indeed, we found that the rat XEN Oct4 mRNA is translated into a protein of 
the same length as in mouse ES cells (Fig. 7B). However, with a dilution series of ES 
Cells Species Strain Line Oct4 mRNA enrichment 
CX1 A 2.10±0.41§ (7) 
B
 0.19±0.05§ (3) 
0.84*/0.30* (2) 
C
 0.62*/0.67* (2) 
WKY 
 
CX5 0.47* (2) 
Rat 
 
BDIX CX2 0.22±0.1§ (4) 
NMRI CX4 0.003±0.001(4)* 
XEN 
 
Mouse 
B6xBalb/c CX6 0.0003* (2) 
ES Mouse 129 D3 1.00* (reference) 
(§)Microsamples, (*) whole culture samples. Samples (numbers in brackets) were RNA-
extracted, RNA preparations were DNAse-treated and quantified in duplicate by real-
time RT-PCR using dual-specific (mouse=rat) primers; controls without reverse 
transcriptase did not yield a product. Data (Means±SEM) were normalized to hprt 
mRNA and expressed as fold of the level in ES cells, i.e. ES cell level is set as 1. A, B, 
two groups of microsamples with high and moderate oct4 mRNA expression, 
respectively. Two experiments labeled C were corrected for feeder RNA; the other 
measurements are underestimates. 
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cells, we estimated the Oct4 content in the rat XEN cells as ~5% of the ES cell level 
(Fig. 7C), which is lower than one would expect from their average Oct4 mRNA level 
(30-80% of ES cells on a whole culture level, Table 3). Because of this discrepancy, we 
wondered whether in addition to the regular Oct4 mRNA, a pseudogene-encoded RNA 
is expressed by rat XEN cells, as recently seen in human tumors and pluripotent cells 
(Suo et al., 2005; Pain et al., 2005). A BLAST search of the rat genome database 
revealed two retrotransposons, one highly homologous and full-length (chromosome 13) 
and one moderately homologous and truncated (chromosome X), in addition to the Oct4 
gene (chromosome 20). We verified that the oct4 mRNA is not pseudogene-encoded by 
using a PstI restriction-length polymorphism (Fig. 7D). Since according to the known rat 
genome sequence, the oct4 cDNA and the chromosome 13 pseudogene amplicon differ 
by a PstI restriction site, we digested the cDNA product (obtained from a DNAse-treated 
RNA sample) in parallel with the putative pseudogene product. As shown in Fig. 7D, the 
cDNA and genomic products produced different PstI digestion patterns, exactly as 
expected from the Oct4 gene and the chromosome 13 pseudogene, respectively. That is, 
digestion of the cDNA product yielded 3 bands consistent with the expected pattern of 
141, 70, and 61 bp, while the genomic product yielded 2 bands consistent with the 
expected pattern of 211 and 61 bp. This result established conclusively that the XEN 
oct4 mRNA is not encoded by a retrotransposon. 
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Fig. 7. Cultured rat XEN cell lines express true Oct4 gene. (A) Northern blot analysis 
of rat XEN (CX1, different passages), mouse XEN (CX4), mouse ES (D3) cells, MEF 
(mouse embryonic fibroblast feeder) and Li1 (rat feeder cell line) (Contributed by 
S.Adhikari). (B) Western blot for Oct4 in rat XEN (CX1), mouse XEN (CX4), mouse 
ES (D3) cells, and rat feeder cell line (Li1) using a monoclonal anti-oct4 antibody; 50 µg 
of protein loaded. (C) Estimate of Oct4 protein content in two independent rat XEN cell 
cultures; the indicated amounts of cell protein were loaded.  (D) PstI restriction length 
polymorphism showing that the XEN oct4 cDNA amplified by RT-PCR corresponds to 
the predicted gene rather than the pseudogene. Dual-specific (rat=mouse) primers were 
used for PCR with cDNA from DNAse-treated rat XEN cell RNA (lane 2, 3) and 
genomic XEN cell DNA (lane 4, 5). The amplicons were digested with PstI (cDNA 
digest, lane 3; genomic DNA digest, lane 5). Lane 1, molecular weight marker (100-bp 
ladder). The detected bands correspond to the patterns expected from the digestion of the 
oct4 gene (chromosome 20)-derived cDNA product (141, 70, and 61 bp on lane 3) and a 
pseudogene (chromosome 13)-derived genomic product (211 and 61 bp on lane 5), 
respectively. pgDNA, pseudogene DNA. 
 
 
Rat XEN cell lines are heterogeneous. In order to know whether the low Oct4 protein 
level resulted from a generally low expression or from heterogeneity of rat XEN cells, 
we performed immunocytochemistry. We used line CX1 and found that Oct4 was 
expressed at high, ES-like levels in 5-15% of rat XEN cells while the remaining rat XEN 
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cells exhibited very low but detectable amounts of Oct4. Mouse ES cells were 
homogeneously positive whereas mouse XEN cells were free of Oct4 (Fig. 8A). In 
addition, immunocytochemistry for Gata6 confirmed that mouse ES cells were free of 
Gata6 while both mouse XEN cells and rat XEN cells expressed it (Fig. 8B). 
Interestingly, many rat XEN cells showed a higher Gata6 level than mouse XEN cells, in 
line with the results of the northern blot and RT-PCR. We extended the analysis of 
heterogeneity by studying the ICM/ES cell marker SSEA1 (Solter and Knowles, 1978), 
and the PrE/VE marker SSEA3 (Shevinsky et al., 1982). As expected, a minority 
fraction of rat but not mouse XEN cells expressed SSEA1 at a proportion comparable 
with the Oct4-positive fraction (Fig. 8C). SSEA3 was expressed in the majority of rat 
XEN cells but was missing from the mouse XEN and ES cells (Fig. 8D); this is in line 
with the RT-PCR results that had shown a greater abundance of VE markers in rat than 
mouse XEN cells. Similar to Oct4 and SSEA1, alkaline phosphatase, another ICM/ES 
marker (Hahnel et al., 1990; Strickland and Mahdavi, 1978), was expressed by many 
round cells in the rat XEN cultures while it was absent from mouse XEN cells (Fig. 8E), 
confirming heterogeneity. To see whether Oct4 and SSEA1 are reproducibly expressed 
in all rat XEN cell lines, we examined line CX2 for expression of Oct4 and SSEA1 and 
line CX5 for SSEA1 expression. As shown in Fig. 9, these cell lines also expressed Oct4 
and SSEA1 but at lower levels than line CX1. 
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Fig. 8. Heterogeneous expression of embryonic marker genes in rat XEN cells. Rat 
XEN (line CX1), mouse XEN (line CX4), and mouse ES (line D3) cell lines were 
analyzed by indirect immunofluorescence with antibodies specifically recognizing Oct4 
(A), Gata6 (B), SSEA1 (C), or SSEA3 (D), or they were stained for alkaline phosphatase 
activity (E). Controls in which primary antibodies were omitted were negative and are 
not shown. Upper rows show immunofluorescence, lower rows show bright field 
images. 
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Fig. 8. Continued. 
 
 
 
 
 
 
 
 
 
Fig. 9. Expression of Oct4 and SSEA1 by other rat XEN cell lines. (A) Line CX2 
expressed Oct4 when analyzed by immunocytochemistry. (B) SSEA1 expression in 
Lines CX2 and CX5. Expression in both lines was lower than line CX1 (Compare Fig. 
8A, B) Upper row, immunofluorescence; lower row, bright field (original magnification 
20x). 
 
Heterogeneity of rat XEN cells is intrinsic. In view of the heterogeneity, we wondered 
whether our cultures contain cells that individually express several of the markers that 
define the ICM-stage XEN-precursor; and whether the culture heterogeneity results from 
E 
Line CX2 Line CX5 
B A 
Line CX2 
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differentiation of such cells or is a result of the parallel proliferation of a mix of lines 
representing different stages. We therefore performed two types of analyses. 
In the first approach, we plated the cells at clonal density and studied the 
resulting colonies over time by immunocytochemistry for expression of the ICM 
markers Oct4 and SSEA1, the pan-XEN marker Gata6, the PrE/VE marker SSEA3, and 
the PE markers laminin B and collagen IV (Strickland et al., 1980; Gardner, 1983).  
Strikingly, nearly all colonies consisted initially (2-3 days after plating) entirely or 
almost entirely of round cells that highly co-expressed Oct4, Gata6, and SSEA1 (Fig. 10 
A,B) while lacking the PrE/VE marker SSEA3 (Fig. 10C) as well as the basement 
membrane components laminin B (Fig. 10D) and collagen IV (Fig. 10E) that are 
characteristically produced by differentiated XEN cells and especially PE. The young 
colonies were poorly adherent and very easily lost during washing steps. By contrast, in 
older, larger colonies (4-7 days after seeding), the inner cells became epithelial, and 
many round as well as the epithelial cells were negative for SSEA1 and very low in 
Oct4. Rather, many of the round cells now expressed SSEA3 (Fig. 10C), and the 
epithelial areas contained abundant extracellular laminin B (Fig. 10D) and collagen IV 
(Fig. 10E). Notably, however, Oct4/SSEA1-positive cells always persisted at the colony 
fringes and showed also higher Gata6 levels than the rest of the colony (Fig. 10 A,B). 
With further evolution of the colony (7-14 days after seeding), the round fringe cells 
kept proliferating and piled up on top of the colonies (Fig. 11) before eventually (10-20 
days after seeding) converting into bridge-like ductal structures that were not 
investigated. 
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Fig. 10. Colony-level analysis of rat XEN cell lines for selected lineage markers. Rat 
XEN cells (line CX1) were plated at low density. At different time points, the resulting 
colonies were stained with the indicated antibodies and counterstained with Hoechst dye. 
(A) Double staining for Oct4 (green) and Gata6 (red).(B) Double staining for Oct4 (red) 
and SSEA1 (green). (C) Staining for SSEA3. (D) Staining for laminin B. (E) Staining 
for collagen IV. BF, bright field. 
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Fig. 11. Continued proliferation and preferential accumulation of SSEA1-positive 
cells in old rat XEN cell colonies. Two magnifications of a representative 16-days old 
colony (line CX1) are shown. Control omitting primary antibody was negative and is not 
shown. BF, bright field. 
 
In the second approach, we transfected the rat XEN cells stably with a neomycin 
resistance marker, a method that ensures single-cell origin despite problems to trypsinize 
the XEN cells to homogeneous single cell suspensions. We obtained and expanded these 
single-cell derived colonies and randomly selected three of them for analysis by 
immunocytochemistry and RT-PCR using known markers of the different stages of 
XEN. All the resulting clones showed identical heterogeneous morphology (round-
epithelial), the same heterogeneous expression patterns of Oct4, Gata6, SSEA1, and 
SSEA3 (Fig. 12A) as well as the same mixed ICM/PrE/VE/PE marker gene expression 
(Fig. 12B) as the parent line. 
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Rat XEN cells repopulate both visceral and parietal yolk sacs. In order to test the 
developmental potential of rat XEN cells, we transduced rat XEN cell lines CX1 and 
CX5 with the GFP-expressing lentiviral vector FUGW (Lois et al., 2002) and sent them 
to our collaborators at Northwestern University, Chicago. There the labeled cells were 
plated at low density to enrich for the XEN-precursor cells and then were injected into 
rat and mouse morulae and blastocysts, followed by culture or uterine transfer. Upon 
injection into rat and mouse morulae and blastocysts, labeled cells moved into the ICM 
(9%), onto the ICM (22%), and to the remaining inner surface of the blastocyst cavity 
(20%), positions that are compatible with XEN-precursor, PrE/VE, and PE identities, 
respectively. Unexpectedly, we also observed incorporations into the trophectodermal 
layer (50%), more often in mouse than rat embryos (Fig. 13A, Table 4). After 
implantation, the labeled cells proliferated and contributed to the PE (79%) and VE 
(18%) layers of rat and mouse yolk sacs (Fig. 13B, Table 5). Thus, the cultured rat XEN 
cells contributed more than sporadically to the VE, although they did more often 
contribute to the PE (Table 5). No integration into fetal tissue was observed. 
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Fig. 12. Lineage marker expression in clonal rat XEN cell lines. Three arbitrarily 
picked subclones of line CX1 were analyzed by (A) indirect immunofluorescence for 
Oct4, Gata6, SSEA1and SSEA3 (Compare to Fig. 8) or (B) RT-PCR for expression of 
selected lineage markers. Cells used: rat XEN (CX1), mouse XEN (CX4), mouse ES 
(D3) cells and rat TE-like cells (B10). (Compare to Fig. 6B). 
 
B 
Clones 
A 1 2 3 
O
ct
4 
G
at
a6
 
SS
EA
1 
SS
EA
3 
20x 
     
50 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 13. Contributions of cultured rat XEN cells to preimplantation and 
postimplantation embryos.  (A) Representative photographs showing in vitro 
incorporation of microinjected rat XEN cells into blastocyst regions that correspond to 
(a) ICM (mouse morula injected); (b) PrE/VE on top of ICM (rat blastocyst injected); 
(c) PE (arrowhead) and mural TE (asterisk) (mouse blastocyst injected); (d) polar TE 
(rat morula injected). (B) Representative fluorescence (a-d) and bright field (a’-d’) 
photographs demonstrating in vivo contributions of microinjected rat XEN cells to (a, 
a’) parietal yolk sac of a 9.5 dpc rat conceptus (inset showing magnification; (b, b’) 
visceral endoderm of a 7.5 dpc rat conceptus; (c, c’) visceral endoderm (arrowheads; one 
patch magnified in inset) and parietal endoderm (asterisk) of a 6.5 dpc mouse conceptus, 
and (d, d’) visceral endoderm of a 7.5 mouse conceptus. (Contributed by Dr. V.Galat) 
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Table 4. Incorporation of cultured rat XEN cells into blastocysts 
No. of 
Expts* 
Cell 
line 
Host 
species 
Injected 
embryos 
 
Stage 
Developed 
to blast. 
 
ICM 
PrE/ 
VE 
 
PE 
 
TE 
1 CX1 12 Blast. n.a. 1 2 2 2 
2 CX5 
Rat 
12 Morula 11 1 4 2 2 
1 11 Morula 10 1   8 
2 
CX1 
9 Blast. n.a.  1 2 8 
1 8 Morula 6    1 
2 
CX5 
Mouse 
24 Blast. n.a. 1 3 3 2 
Total 
(%) 
4 
(8.7) 
10 
(21.7) 
9 
(19.6) 
23 
(50) 
* A total of 66 rat and 57 mouse embryos were injected in 7 experiments each. 
Included in the table are only those experiments in which after in vitro culture, labeled 
cells could be traced to blastocyst structures, which include inner cell mass (ICM), 
primitive or visceral endoderm (PrE/VE), parietal endoderm (PE), and trophectoderm 
(TE). (Contributed by Dr. V.Galat) 
 
 
 
Table 5. Incorporation of cultured rat XEN cells into postimplantation conceptuses 
 
No. of 
Expts* 
Cell 
line 
 
Host 
species 
Injected 
embryos 
Implantat
-ion sites 
Regressed 
embryos 
Recovery 
day 
VYS PYS Unclear 
3 CX1 Rat 30 24 5 8.0-9.0 2 1  
4 CX5 Rat 59 39 9 8.5-9.5  7  
3 CX1 Mouse 34 25 15 7.0-8.0 3 6 1 
4 CX5 Mouse 59 37 20 7.5-8.5  7  
Total 
(%) 
5 
(19) 
21 
(78) 
1 
(3.7) 
* A total of 145 rat and 168 mouse embryos were injected and transferred in 13 and 
15 experiments, respectively. Included in the table are only those experiments in 
which labeled cells could be recovered in a structure of the intact conceptus, including 
visceral yolk sac (VYS) endoderm and parietal yolk sac (PYS) endoderm (Contributed 
by Dr. V.Galat). 
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Discussion 
We present here rat XEN cell lines that exhibited the molecular signature (Oct4+ 
Gata6+ SSEA1+ Nanog-Cdx2- Sox2-) expected from the XEN-precursor and give rise 
to its expected products, namely PrE/VE and PE in vitro and the respective yolk sac 
membranes in vivo. Our results show that cultured rat XEN cells highly express the key 
pluripotency marker Oct4 while mouse XEN cells did not contain significant Oct4 
mRNA levels, as known before (Kunath et al., 2005). The expression of Oct4 is 
associated with cells having totipotent or pluripotent differentiation ability (Rosner et al., 
1990; Scholer et al., 1990b; Yeom et al., 1996). However, Oct4 mRNA has previously 
been detected in the PrE layer of blastocysts (Rosner et al., 1990) and in the PrE/VE 
layer of embryoid bodies (Hamazaki et al., 2004). Although the average Oct4 mRNA 
levels in the rat XEN cells were fairly variable and somewhat lower than in ES cells, 
peak Oct4 mRNA levels in rat XEN cell colonies were even higher than those of mouse 
ES cells using qRT-PCR (Table 3). This is in line with the observation that over-
expression of Oct4 in undifferentiated ES cells leads to endodermal differentiation 
(Niwa et al., 2000) and that a transient surge of Oct4 mRNA level accompanies the RA 
differentiation of F9 EC cells into endoderm (Botquin et al., 1998). However, Nanog, 
Sox2, and Fgf4, which are known Oct4 target genes and commonly used EPI markers, 
were not expressed in the rat XEN cells excluding the presence of ES-like cells. By 
contrast, the Rex1 gene, which is also an EPI marker and Oct4 target gene (Hosler et al., 
1993; Ben-Shushan et al., 1998; Shi et al., 2006), was expressed in rat but not mouse 
XEN cells suggesting that Oct4 in the rat XEN cells is functional. This result parallels 
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the co-expression of Oct4 and Rex1 in Nanog-deficient mouse ES cells, which are XEN-
like (Mitsui et al., 2003). Moreover, our results revealed that the rat XEN, but not mouse 
XEN, cells expressed the ICM/ES cell markers SSEA1 and alkaline phosphatase in a 
significant minority of the cells similar to Oct4 expression. 
The findings that cultured rat XEN cells show a cluster of features traditionally 
considered as characteristic of mouse ES cells and ICM, in addition to expressing XEN 
markers strongly suggest that cultured rat XEN cells represent the ICM-stage XEN 
precursor (Chazaud et al., 2006; Kurimoto et al., 2006). More precisely, ~5-15% of the 
rat XEN cells (those with high Oct4 protein levels) are XEN-precursor cells while a 
larger fraction appears to represent the PrE stage, which is also missing in mouse XEN 
cell cultures. Indeed, we observed that there is a higher Oct4 mRNA level in the rat XEN 
cell cultures than reflected by the amount of protein, implying that some of the rat XEN 
cells that are low in Oct4 protein still express the mRNA, similar to what has previously 
been observed in the XEN layer on the surface of mouse ES cell-derived embryoid 
bodies (Hamazaki et al., 2004). In line with this, the majority of cultured rat XEN cells 
express SSEA-3, which is considered a PrE marker (Shevisnky et al., 1982) while mouse 
XEN cells that are PE-like (Kunath et al., 2005) lack SSEA3. Interestingly, we also 
noted that our rat XEN cell cultures showed higher levels of the pan-XEN marker Gata6 
and of the VE/PrE markers Foxa2 and Dab2 than mouse XEN cells. Further, rat but not 
mouse XEN cells also expressed Eomesodermin, which marks the TE and the anterior 
visceral endoderm (Ciruna and Rossant, 1999) while Cdx2 and placental lactogen were 
not expressed in all XEN cell lines excluding TS-like cells in the culture. In summary, 
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while the mouse XEN cell lines were largely PE-like as expected (Kunath et al., 2005), 
the rat XEN cell lines expressed markers of all stages of the XEN lineage (XEN-
precursor, PrE/VE, and PE). 
The analysis of cells at low density showed that young/small colonies co-
expressed Oct4, Gata6 and SSEA1 (Fig. 10A,B). Thus, young colonies show the key 
marker pattern of the XEN-precursor (Chazaud et al., 2006; Kurimoto et al., 2006). 
These colonies were poorly adherent and very easily lost during washing steps, in line 
with lack of expression of the basement membranes laminin B and collagen IV. This 
might explain why the young colonies that survived washings tended to have one or two 
differentiating cells that anchored them, and implies that the immunocytochemistry 
experiments with whole cultures (Fig. 8) underestimated the true percent of Oct4 and 
SSEA1 positive cells. By contrast, the majority of cells in older/large colonies expressed 
no or low Oct4, and lower Gata6 levels but additionally expressed differentiated XEN 
markers SSEA3 (PrE/VE)(Shevinsky et al., 1982) and laminin and collagen IV (PE) 
(Strickland et al., 1980; Gardner, 1983). In line with the high deposition of the basement 
membranes (Fig. 10D, E), older colonies became firmly adherent and contained a large 
fraction of epithelial cells. In further experiments, single-cell derived clones expanded to 
a whole culture level were able to give rise to the heterogeneous culture known from rat 
XEN cells providing formal evidence that one XEN-precursor cell can generate the 
whole culture heterogeneity. 
Taken together, the gene expression studies in combination with colony and clonal 
analyses demonstrate that (i) Our rat XEN cell lines contain XEN-precursor cells (Oct4+ 
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Gata6+ SSEA1+ Nanog- Cdx2-Sox2-); (ii) The XEN-precursor cells are the principal 
self-renewing entity under our current culture conditions, since they give rise to most, if 
not all, colonies; (iii) Culture heterogeneity is intrinsic and results from XEN-precursor 
cell differentiation into PrE/VE (SSEA3+) and PE (laminin+, collagen IV+). In addition, 
these data suggest that XEN-precursor cells can be enriched by SSEA1 sorting. The 
findings that our rat XEN cultures contain XEN-precursor cells that undergo both self-
renewal and differentiation to the next XEN stages resembles cellular hierarchies 
recently discovered within human ES cell cultures that involve heterogeneity and 
posttranscriptional downregulation of Oct4 (Stewart et al., 2006). 
Investigation of the developmental potential of rat XEN cells showed that they 
retain the capacity to contribute to visceral and parietal endoderm in vivo in chimeras, 
confirming to their XEN lineage origin. Although the overall contribution was biased 
towards the PE, line CX1 that showed a higher percentage of SSEA1-positive cells than 
CX5 (Figs. 8B, 9B) contributed at a relatively high frequency to the VE. This 
observation is in line with the previous findings that freshly isolated ICM cells 
contribute well to both VE and PE while freshly isolated PrE and VE cells mainly go to 
the PE (Gardner, 1982; Gardner, 1984). The predominant incorporation to the PE could 
also be a result of the blastocyst injection procedure used to generate chimers that may 
have provided an environment that promotes PE and hinders VE differentiation. In post-
implantation embryos, no contribution into fetal or trophoblast tissue was detected. 
However, integrations into the TE layer of the blastocysts were observed (Fig. 13Ad). 
This TE-integration was unlikely due to contamination with TE-committed cells, 
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because our rat XEN cells lack Cdx2 that is required for TE commitment and expressed 
in the early TE as well as in rat and mouse TE-like and TS cell lines (Tanaka et al., 
1998; Buehr et al., 2003; Strumpf et al., 2005; Niwa et al., 2005). Besides, TS cell 
expression pattern was not seen in single-cell derived clones. It is important to 
emphasize here that given all cell types in the XEN cultures originate from a single cell 
in vitro (Fig. 12B), all phenotypes seen in vivo derive at least indirectly from cultured 
XEN precursor cells. In line with the molecular analyses described above and the 
capacity to differentiate in vitro, the comparable ability of cultured rat XEN cells to 
integrate into rat and mouse embryos indicates that these cultures contain cells that are 
not principally different from primary XEN-precursor cells known from the mouse 
(Chazaud et al., 2006). 
The availability of the XEN-precursor cell lines, which can differentiate into 
XEN subtypes in vitro and contribute to normal development in chimeras in vivo, 
provide a unique model for an early mammalian lineage that will complement the 
established ES and TS cell lines. In vitro combinations of ES, TS and XEN-precursor 
cells may help model the in vivo interactions between embryonic and extraembryonic 
lineages important for embryonic patterning (Kunath et al., 2005; Rossant, 2007). Using 
these cell lines, insights will be gained about the nature of the XEN-precursor, its 
differentiation and potential plasticity, and the developmental roles of the XEN lineage. 
It will also be interesting to compare the XEN-precursor with their better studied ES cell 
siblings for specific molecular features, such as overall epigenetic and X-chromosome 
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status, role and regulation of Oct4, and the signaling pathways involved in self-renewal 
(Niwa, 2007; Surani et al., 2007; Yeom et al., 1996; Chambers and smith, 2004). 
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CHAPTER III 
 
REGULATION OF OCT4 GENE EXPRESSION IN RAT YOLK SAC 
ENDODERM STEM CELL LINES 
 
Overview 
The transcription factor Oct4 is a key regulator of pluripotency that is regarded as 
a hallmark of ES cells. It has been shown that the Oct4 gene contains a distal enhancer 
that drives specific expression in preimplantation embryos and ES cells and a proximal 
enhancer that activates expression in the epiblast and EC cells. But so far Oct4 
regulation has not been described in the XEN lineage. We used the Oct4-expressing 
XEN-precursor cell lines, which were isolated in our laboratory, to identify regulatory 
elements responsible for Oct4 expression in the XEN cells. We divided the 5’ flank of 
the mouse Oct4 gene into Region I (~2.7 kb) that contains the known enhancers and 
Region II (~1.9 kb) that is unexplored before and is upstream of Region I. We found that 
the rat XEN cells express reporter genes driven by Region (I+II) but do not express a 
reporter gene driven only by Region I. Our findings show the existence of differential 
Oct4 regulation between mouse ES and rat XEN cells and that a novel enhancer drives 
high-level gene expression in the rat XEN cells. 
 
Introduction 
Oct4 is a crucial determinant of pluripotency in ES cells (Nichols et al., 1998; 
Niwa, 2007) and is one of only four factors required to induce ES-like pluripotency in 
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fibroblasts (Yamanaka and Takahashi, 2006; Okita et al., 2007; Wernig et al., 2007). 
Oct4 is also essential for the differentiation of ES cells (Niwa et al., 2000). A critical 
level of Oct4 is required to maintain stem cell renewal in ES cells, and the level of Oct4 
expression need to be tightly regulated in order to determine pluripotency and cell fates 
in preimplantation development (Niwa et al., 2000; Niwa, 2007). Therefore, 
investigation of the mechanisms that regulate Oct4 levels is important for understanding 
early embryonic development, pluripotency and differentiation. 
Previous studies have defined three regulatory regions that are important for 
driving Oct4 expression in stem cells and in developing embryos (Okazawa et al., 1991; 
Sylvester and Scholer, 1994; Yeom et al., 1996). These regulatory regions include the 
TATA-less proximal/minimal promoter that mediates Oct4 basal promoter activity 
(Okazawa et al., 1991; Sylvester and Scholer, 1994) and two enhancer elements (distal 
enhancer and proximal enhancer) located in a 3-kb region upstream of the proximal 
promoter. These regulatory elements have been discussed in detail in chapter I under the 
subtitle ‘regulation of Oct4 gene expression’. 
The observation that the distal enhancer is the principal Oct4 enhancer in the 
ICM and ES cells (Yeom et al., 1996) was made before it became apparent that the ICM 
is a heterogeneous population consisting of the EPI-precursor and XEN-precursor cells 
that both express Oct4 (Chazaud et al., 2006; Kurimoto et al., 2006). ES cells are now 
thought to be the in vitro equivalents of the EPI-precursor (Chazaud et al., 2006; 
Yamanaka et al., 2006) while our laboratory has isolated and characterized cell lines 
representing the XEN-precursor cells. Unlike in ES cells where the regulatory elements 
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that drive Oct4 expression are well characterized, it is unknown whether such elements 
exist in the rat, and which one of the known enhancers would be active in the Oct4-
expressing rat XEN cells. In this study we show that the 5’ region of the mouse Oct4 
gene is active in the rat XEN cells. Further examination of this region revealed a 
previously unknown enhancer that drives Oct4 expression in rat XEN cells and that 
mediates differential regulation in mouse ES and rat XEN cells. 
 
Materials and methods 
Cell lines and cell culture 
Mouse ES (line D3), mouse XEN (lines CX4, CX6) and rat XEN (lines 
CX1,CX2, CX5) cells were grown in DMEM containing glutamine and sodium 
pyruvate, 15% (v/v) ES-qualified serum (Invitrogen), 0.1 mM   -mercaptoethanol,  100 
U/ml of Penicillin and 100 ug/ml streptomycin, and 1000 u/ml of LIF. Cells were seeded 
by trypsinization (0.25% trypsin-EDTA) at 37 °C and 5% CO2. Passaging was performed 
every other day. Rat feeder cell line (Li1) and primary mouse embryonic fibroblasts 
were grown in DMEM with glutamine and sodium pyruvate, 100 U/ml of penicillin and 
100ug/ml streptomycin and 10% fetal calf serum. The feeders were passaged at 1:4 to 
1:6 split (as needed) in a 10-cm plate. Both mouse and rat feeders were inactivated using 
mitomycin (10µg/ml) i.e., by adding 10µl of mitomycin per 10ml of media in a 10-cm 
tissue culture plate and incubating it overnight at 37oC. Following mitomycin treatment, 
the plates were washed 2X with PBS and were either trypsinized and seeded or stored in 
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the incubator until use. A 10-cm feeder dish was commonly seeded into 4x6-cm plates 
(about 1,000,000 cells per 6-cm plate). 
Reporter gene constructions 
The schematic description of the reporter constructs used in this study is shown 
in Fig. 14. In order to generate a fragment containing the two known Oct4 gene 
enhancers (distal and proximal enhancers), we used a bacterial artificial chromosome 
(BAC) clone (RP23-75C13 - obtained from CHORI BACPAC resource center, Oakland, 
CA) that contains the mouse Oct4 locus. We amplified fragment 1 (-2695/+1; the 
numbering of nucleotides in this study is according to Nordhoff et al. (Nordhoff et al., 
2001), i.e. the position relative to the translational start site) using the primer sequences: 
5’-cacccggcccaaagtgactc-3’ and 5’-aggtgggcaccccgagc-3’  and a high-fidelity enzyme 
Accuprime Pfx (Invitrogen) by 7 PCR cycles (94 °C, 30 sec; 65 °C, 30 sec; 68 °C, 
3:30 min). Fragment 1 was then cloned into the SmaI site of the pGL3-Basic vector 
upstream of the firefly luciferase gene (Promega). The resulting construct (called Region 
I) was verified by sequence analysis. Region I was then used to further reconstruct 
another luciferase reporter gene which contains only the minimal Oct4 promoter (called 
here Proximal promoter). This construct was made by replacing the NheI/XbaI fragment 
of pGL3-Basic vector with the XbaI/XbaI fragment from Region I construct. The 
proximal promoter served as a background control. In order to determine if Oct4 in the 
rat XEN cells is regulated independently of mouse ES cell enhancers, another fragment 
(-4614/-2641, called here fragment 2) was amplified using Sahara DNA polymerase 
(Bioline, MA, USA) from plasmid GOF-9 (kindly provided by Dr. Yeom; Yeom et al., 
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1996) that contains the mouse Oct4 gene plus a LacZ reporter “knocked in” the 
endogenous start codon. For this amplification, we used primers which contained the 
MluI restriction site (bold) (5’-attacgcgttcctagcggggagac-3’ and 5’-
catacgcgtatatgtgccactctgcc-3’) and 15 total PCR cycles (5 cycles of 94 °C, 30 sec; 53°C, 
30 sec; 72 °C, 3 min; and 10 cycles of 94 °C, 30 sec; 66°C, 30 sec; 72 °C, 3 min). 
Fragment 2 was then cloned into the MluI site of the Proximal promoter and we 
designated this construct Region II (Fig. 14). The last construct (called Region (I+II)) 
was generated by cloning the PCR fragment 2 into the MluI site of Region I. For all 
constructs the right orientation was confirmed by PCR and restriction enzyme digestion. 
 
 
 
 
 
 
Fig. 14. Scheme of Oct4 gene depicting the main fragments analyzed in the reporter 
gene assays. Oct4 gene exons are symbolized with black boxes and the transcription 
start site with a bent arrow. 
 
Lacz assay with histochemical stain 
We seeded mouse ES, Mouse XEN, rat XEN cells as well as rat feeder cells in 4-
well plates overnight and transfected them with 1µg/well of plasmid GOF-9 (Yeom et 
al., 1996) using lipofectamine 2000 reagent (Invitrogen, CA). Non-transfected controls 
Proximal promoter 
Region I 
Region II 
Region (I+II) 
~4.6 kb 
Oct4 I II 
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were included for each cell type. After 48 hrs, the   -galacosidase activity was visualized 
in situ by the histochemical stain method described (Sambrook and Russell, 2001). 
Briefly, media was removed and cells rinsed twice with PBS. Cells were then fixed with 
cell fixative (2% formaldehyde, 0.2% glutaraldehyde, 1x PBS) for 5min at room 
temperature. After washing with PBS three times, cells were stained with a 
histochemical stain (5mM potassium ferricyanide, 5mM potassium ferrocyanide, 2mM 
MgCl2, 1mg/ml X-gal, 1x PBS), incubated for 24 hrs at 37oC, rinsed with PBS and 
photographed under a bright field microscope. 
 
Quantification of   -galactosidase activity 
We used the   -galactosidase Enzyme Assay System (Promega) for quantification 
of the   -galactosidase activity in transfected mouse ES, mouse XEN, rat XEN and rat 
feeder cell lines. Cells were seeded overnight in 6-well plates and were co-transfected 
with a mix (2µg/well, molar ratio 200:1) of GOF-9 construct and an SV40-driven pGL3-
control vector (Promega)-to normalize transfection efficiency. After 48 hrs, the cells 
were washed twice with PBS and lysed with the reporter lysis buffer for 15 min at room 
temperature. The cells were then collected with a scraper and centrifuged to remove cell 
debris. The cell lysate was split and assayed for   -galactosidase and luciferase assay 
systems. The   -galactosidase activity was assayed (in duplicate) by mixing 50µl of the 
cell lysate in a 96-well plate with an equal volume of 2x assay buffer and was incubated 
at 37oC for 2-3 hrs, followed by measurement of the absorbance (415 nm) with a plate 
reader. The luciferase activity was measured (in triplicate) using the luciferse assay 
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system (Promega) in a 96-well Luminocount luminometer (Packard Instruments). The   -
galactosidase activity was then divided by luciferase activity in order to correct for 
differences in transfection efficiency. 
Luciferase assays 
Mouse ES (2.0 × 104), mouse XEN (4.0 × 104), rat XEN (4.0 × 104) and rat 
feeder (4.0 × 104) cells were seeded in 96-well bottom-clear tissue culture plates 
(PerkinElmer, MA, USA) for 24 hrs. 100 ng of the firefly luciferase constructs along 
with 2 ng of the Renilla luciferase (pRL/TK, Promega) was transfected using Fugene HD 
(Roche). The pRL/TK plasmid served as an internal control for normalizing the 
transfection efficiency. The cells were lysed 48 hrs after transfection and firefly and 
Renilla luciferase activities were measured with the Dual-Glo Luciferase Assay System 
(Promega). Because of problems with lysis when following the manufacturer’s 
procedure, we modified it by removing the medium, freezing the plates at –80oC for 5 
min, equilibrating to room temperature, adding the media back and then an equal volume 
of the dual-glo luciferase assay reagent. Plates were read in a Luminocount 96-well 
luminometer from Packard Instruments. The luciferase activity of each construct was 
calculated relative to the pGL3-Basic vector, which lacks a promoter and enhancer 
region. All transfection experiments were repeated in triplicate and promoter activities 
are reported as means ± SEM. In order to correct for variations in transfection efficiency, 
readouts of firefly luciferase-encoding Oct4 reporter plasmids were divided by the 
values determined for the Renilla luciferase-encoding plasmid pRL-TK which had been 
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co-transfected at a ratio of 1 molecule pRL-TK per 50 molecules of Oct4 gene reporter 
construct. 
 
Results 
A mouse Oct4 reporter gene is active in rat XEN cells. In order to test whether the 
mouse Oct4 gene confers reporter gene expression in the rat XEN cells, we transiently 
transfected the GOF-9 reporter gene construct that includes the Oct4 gene and a LacZ 
cDNA cloned into the start codon (Yeom et al., 1996). The cells were stained using a 
histochemical stain 48 hrs after transfection. As shown in Fig. 15, GOF-9 stained 
positively for beta galactosidase not only in mouse ES cells but also in rat XEN cells 
while mouse XEN cells that do not express Oct4 (Fig. 6B; Kunath et al., 2005) and rat 
fibroblasts were negative. 
We then quantified the beta galactosidase activity using   -galactosidase Enzyme 
Assay System after transfecting the cells with GOF-9. Similar to the qualitative 
histochemical stain, GOF-9 was active in mouse ES cells and rat XEN cells but no 
activity was seen in mouse XEN cells and in rat fibroblasts (Fig. 15B). The average 
relative level of GOF-9 expression in the rat XEN cells was ~30% of the level in ES 
cells. This was comparable with the average relative level of endogenous Oct4 mRNA. 
The lower average beta galactosidase activity in the rat XEN vs. the mouse ES cells 
could be partly attributed to the heterogeneity observed in rat XEN with respect to Oct4 
mRNA levels; Not only are the differentiated cells lowly expressing Oct4 but the 
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construct that corrects for transfection efficiency will also be incorporated into such cells 
which likely underestimates the Oct4 reporter gene activity. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 15. Cultured rat XEN cells express reporter genes driven by mouse Oct4 
regulatory region. Cells used: D3 mouse ES cells, CX4 mouse XEN cells, CX1 rat 
XEN cells and Li1 rat embryo fibroblast. (A) Histochemical staining for B-galactosidase 
activity after transient transfection with GOF-9 (Yeom et al., 1996). (B) Quantification 
of the reporter gene activity normalized to SV-40 driven luciferase. Non-transfected 
cells did not show LacZ staining. 
 
 
The Oct4 enhancer sequence that is active in cultured rat XEN cells was derived 
from the mouse Oct4 gene construct GOF-9 (Yeom et al., 1996). Although GOF-9 
contains an upstream and downstream region separated by a LacZ reporter placed at the 
start codon, in this study we generated the Oct4-Luc fragments only from the sequences 
of the upstream region because in previous experiment (Yeom et al., 1996), a reporter 
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transgene containing the downstream sequences plus the Proximal promoter was inactive 
in the ICM, whereas the upstream regions lead to expression. 
 
A novel enhancer drives Oct4 expression in rat XEN cells. Having known that the 
mouse Oct4 reporter gene is active in rat XEN cells, we sought to determine whether the 
known regulatory elements (the distal and proximal enhancers) that have previously 
been shown to restrict reporter gene expression to Oct4-expressing cell types (Yeom et 
al., 1996) are also responsible for driving Oct4 expression in rat XEN cells. We first 
tested Region I (see Fig. 14 for scheme), an Oct4-Luc reporter construct containing both 
distal and proximal enhancers, for reporter gene expression in the rat XEN cells. As 
shown in Fig 16, Region I drove robust luciferase expression in mouse ES cells but only 
background expression in rat XEN, mouse XEN and rat fibroblast cells. Thus, Region I 
is insufficient for Oct4 expression in XEN cells. We then tested the other Oct4-Luc 
reporter constructs including Region II, Region (I +II) and the Proximal promoter. We 
found that Region (I+II) construct was active in mouse ES and rat XEN cells but not in 
mouse XEN and rat fibroblast cells while Region II and the Proximal promoter 
constructs did not confer reporter gene expression in any of the cells (Fig. 17). Thus, 
Region I is necessary and sufficient for Oct4 expression in ES cells. But neither Region I 
nor Region II is sufficient, and both regions are necessary for expression in rat XEN 
cells. This shows that a novel or previously unknown transcriptional enhancer is required 
for Oct4 expression in rat XEN cells and that there is differential regulation between 
mouse ES and rat XEN cells. 
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Fig. 16. Previously known mouse ES cell enhancer is insufficient to drive Oct4 
expression in rat XEN cells. Bars show expression levels of Region I luciferase 
reporter construct, normalized for transfection efficiency Cells used: D3 mouse ES cells, 
CX4 mouse XEN cells, CX1 rat XEN cells and Li1 rat embryo fibroblast. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 17. A novel transcriptional enhancer drives Oct4 expression in rat XEN cells. 
Cells used: D3 mouse ES cells, CX4 mouse XEN cells, CX1 rat XEN cells and Li1 rat 
embryo fibroblast. While Region I is sufficient in ES cells, Region (I+II) is required for 
Oct4 expression in rat XEN cells. Bars show luciferase expression levels of the 
luciferase reporter constructs, normalized for transfection efficiency with pRL-TK. 
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Discussion 
Two enhancers, both located within 3-kb upstream of the transcription start site, 
have previously been shown to confer tissue-specific Oct4 gene expression: the distal 
enhancer is active in the ICM and germline in vivo and in ES cells and EG cells in vitro, 
while the proximal enhancer is active in the epiblast in vivo and in EC cells in vitro 
(Yeom et al., 1996). Here we discovered that the 5’ region of the mouse Oct4 gene 
contains previously unknown cis-acting elements that appear to mediate differential 
regulation of Oct4 in mouse ES cells and rat XEN cells. In support of our findings, there 
were indications that Oct4 might be regulated differently in the XEN cells: an increased 
dosage of Oct4 can convert ES cells into XEN cells (Niwa et al., 2000) and the 
differentiation of murine EC cells into XEN cells involves a transient increase of Oct4 
gene transcription (Botquin et al., 1998). Moreover, one report claims that cells of the 
newly forming primitive endoderm expressed Oct4 protein at a level that appears to be 
higher than that seen in the ICM population (Palmieri et al., 1994) although this finding 
was not confirmed by others (Strumpf et al., 2005). Differential Oct4 regulation in 
mouse ES and rat XEN cells might suggest that a significant epigenetic difference is 
established during, if not before, the second embryonic lineage choice when the ICM 
converts to EPI and XEN lineages. 
The reason that previous reporter gene constructs (Yeom et al., 1996; Buehr et 
al., 2003) did not reveal Oct4 gene expression in the XEN-precursor cells in vivo might 
be because the activity of the XEN-enhancer was obscured by the activity of the known 
ICM-enhancer (i.e. the distal enhancer). But with the discovery of the heterogeneity of 
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the ICM (Chazaud et al., 2006) and our finding of a novel XEN-enhancer in the Oct4-
expressing rat XEN cells, the view that the distal enhancer is the only Oct4 enhancer 
used in the ICM may have to be re-interpreted such that both XEN enhancer and ES 
enhancer contributed to the reporter gene expression in the different subpopulations of 
the ICM. 
A systematic dissection and precise identification of the cis-acting element(s) 
driving Oct4 expression in the XEN cells as was done in ES cells (Okumura-Nakanishi 
et al., 2005; Chew et al., 2005; Yeom et al., 1996) might allow the selective inactivation 
of the Oct4 gene enhancer in XEN-precursor cells without affecting it in the EPI-
precursor cells. This will enable us to study the lineage-specific functions of Oct4, 
identify trans-acting factors and optimize the derivation, maintenance and differentiation 
of pluripotent ES cells for therapeutic purposes. 
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CHAPTER IV 
 
SUMMARY AND CONCLUSIONS 
 
During the first embryonic lineage choice, the outer cells of the mammalian 
morula become committed towards the TE lineage while the remaining inner cells 
become the ICM. It has previously been thought that the ICM is composed of a 
homogenous population of cells, and ES cells were usually portrayed as representing the 
ICM. However, we have learned only very recently (Chazaud et al., 2006; Kurimoto et 
al., 2006) that the ICM, during the early blastocyst (E3.5 in the mouse) stage, is 
composed of two intermingled, morphologically indistinguishable populations of cells: 
the EPI-precursor that founds all fetal lineages and the XEN-precursor that founds the 
yolk sac endoderm. 
The EPI-precursor has been well characterized because it is represented in vitro 
by the well known ES cell lines that have been available since1981 (Evans and 
Kaufman, 1981; Martin, 1981). By contrast, cell lines representing the XEN-precursor 
cells are missing. Mouse XEN cell lines described recently (Kunath et al., 2005) do not 
express Oct4 (the hallmark of ICM cells) and do not contribute efficiently to all XEN 
cell types in vivo, and thus they do not represent the XEN-precursor. Our laboratory has 
derived XEN cell lines from rat blastocysts that express the key ICM and pluripotency 
marker Oct4 and we hypothesized that these cell lines represent the XEN-precursor. The 
goals of the work presented here were i) to define the molecular identity of these Oct4-
     
72 
expressing rat XEN cells using molecular and differentiation markers, and ii) to study 
the regulation of Oct4 expression in the rat XEN cells and compare it with that in mouse 
ES cells. 
To achieve our first goal, we used known molecular markers that define the three 
fundamental tissue lineages of the early developing embryo (TE, EPI, and XEN) and 
compared our rat XEN cell lines with mouse XEN, mouse ES and rat TE-like cells. We 
easily detected Oct4 mRNA in cultured rat XEN cells but not in mouse XEN cell lines, 
confirming Kunath et al. (Kunath et al., 2005).  In addition to expressing known XEN 
markers and Oct4, rat XEN cells also expressed Rex1, an ICM marker and a target gene 
of Oct4 but they lacked other ES cell markers and TE markers, excluding their 
contamination with ES/TS cells. In colony samples, the Oct4 mRNA in rat XEN cells 
reached levels >2 fold of those in mouse ES cells, reminiscent of the 2.5 fold increase of 
Oct4 mRNA in murine EC cells differentiating into XEN cells (Botquin et al., 1998). 
But the average Oct4 mRNA from a whole culture ranged from 30-84% indicating 
heterogeneity in the culture. In line with this, we found that only a minority fraction (5-
15%) of Oct4 mRNA-containing rat XEN cells express Oct4 protein at comparable 
levels with that in mouse ES cells. 
We studied colonies over time in order to understand the identity of the Oct4-
expressing XEN cells and examine whether heterogeneity in rat XEN cells is arising 
from differentiation of each XEN cell to the next developmental stage (s). Very young 
colonies showed expression patterns expected from the XEN-precursor. That is, they co-
expressed Oct4/SSEA1 and Gata6 while the PrE/VE marker SSEA3 and the PE markers 
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laminin and collagen IV were absent. As colonies get older, however, most of the cells 
were negative for SSEA1 and Oct4 but rather expressed SSEA3, laminin and collagen 
IV. Yet, the older colonies always retained high Oct4/SSEA1 and Gata6-expressing cells 
at their fringes. By expanding single-cell derived clones into a whole culture level and 
analyzing three of them with immunocytochemistry and RT-PCR, we found a 
heterogeneous morphology, heterogeneous Oct4/SSEA1/SSEA3 staining, and mixed 
XEN-precursor/PrE/VE/PE marker expression. The in vivo developmental potential of 
the rat XEN cells was studied by injecting GFP-labeled cells into rat and mouse 
blastocysts. The injected rat XEN cells showed exclusive contribution to the XEN cell 
types, including both the visceral and parietal endoderm. 
In summary, our results show that rat XEN cells contain the ICM-stage XEN-
precursor, and only XEN-precursor cells gave rise to colonies under our culture 
conditions. These cells can be maintained in vitro as a self-renewable entity just like the 
ICM-stage EPI-precursor of other species can be maintained in the form of ES cells. Our 
results also demonstrate that culture heterogeneity results from the differentiation of 
XEN-precursor cells into PrE/VE and PE and thus, provide a superb in vitro model of 
early differentiation along the XEN pathway. 
The second goal, which is on identifying regulatory elements responsible for 
Oct4 expression in the XEN cells, was accomplished by dissecting the 5’ flank of the 
mouse Oct4 gene sequences (~5 kb) into Proximal promoter, Region I that consists of 
previously known ES cell and epiblast enhancers, Region II that is unexplored before 
and is upstream of Region I, and Region (I+II). We found that Region (I+II) drove 
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luciferase gene expression while neither Region I nor Region II is sufficient for reporter 
gene expression in rat XEN cells. Thus, a previously unknown transcriptional enhancer 
drives Oct4 expression in rat XEN cells and differential Oct4 regulation exists in mouse 
ES vs. rat XEN cells. 
In summary, we here present for the first time cell lines that based on their 
molecular signature and differentiation potential represent the XEN-precursor as known 
from mouse ICM. These cell lines offer new possibilities for examining the nature, 
differentiation, and plasticity of the XEN-precursor and the biological roles of the XEN. 
In particular, determining the role and regulation of Oct4 in XEN-precursor cells will 
help to understand their nature and relationship with the EPI-precursor (Chazaud et al., 
2006) and provide knowledge useful for methods to induce pluripotency (Takahashi and 
Yamanaka, 2006); this is because Oct4 can both protect the identity of ES cells and 
induce their differentiation, including differentiation into XEN (Niwa et al., 2000). 
Likewise, it will be instructive to compare ES and XEN-precursor cells with respect to 
their epigenetic status (Niwa, 2007; Surani et al., 2007) and the signaling pathways 
involved in self-renewal (Chambers and Smith, 2004). Furthermore, our rat XEN cell 
lines offer the first in vitro differentiation model in which XEN cells are generated from 
XEN-precursor cells. This mimics the natural process but contrasts with the traditional in 
vitro model in which XEN cells are generated from ES cells (Doetschman et al., 1985), 
which likely involves trans-differentiation (Chazaud et al., 2006). This work has also 
uncovered new facets on the regulation of Oct4 gene expression at a stage of embryonic 
development that is poorly accessible. Future studies on the new Oct4 gene enhancer 
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will benefit from answering questions such as where exactly is this enhancer located 
(promoter bashing)? Where and when this enhancer is active in vivo? Does the 
differential regulation observed in vitro between XEN-precursor and EPI-precursor (ES 
cells) cells also exist in vivo? Would inactivation of this enhancer in the XEN cells have 
developmental consequences? 
In conclusion, this work provides XEN-precursor cell lines and the newly 
identified enhancer as new tools that will advance understanding of the molecular basis 
of early embryogenesis, and improve the derivation and directed differentiation of 
pluripotent and therapeutic stem cells. 
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